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81 General Introduction
1.1 Calf breeding in Italy
1.1.1 The veal calves breeding
The veal calves breeding usually include males and females of dairy breeds
exceeding the replacement heifers. These animals arrive in the fattening facilities
in the first weeks of life and here they remain for a period of 180 days about,
until to achieve a body weight of 200-220kg.
The distinguishing peculiarities of the veal calves’ meat are achieved through a
diet based on milk replacerer, being completed with a minimum amount of
concentrate.
The industrialization of this type of farming began in 1960 with the ability to
take advantage of the high surplus milk powder produced in northern Europe,
leading to a rapid growth of this sector in the early 90s. The veal calves,
subsequent to colostrum administration are transferred in the fattening centres of
fattening and fed with milk replacer powder for a period of 180 - 200 days until
the achievement of a live weight of 200-250 kg.
Italy is the third largest country at communitarian level in the breeding of veal
calves (18% of total production) after France (31%) and the Netherlands 27%
(Suarez et al., 2006); in this regard Lombardy region alone is able to cope the half
of the national veal calves request.
In the EU, public opinion has always been influencing the agricultural policies
and with regard to veal production, in the last decade the increased public
concern on animal welfare has resulted in stricter regulations on veal production
(Directive 97/2/EC; Directive by the Council of Europe, 1997). In the past, the
provision of solid feeds (either concentrate or roughage) to veal calves was
deliberately avoided by believing that this practice would have a negative effect
on milk intake, feed conversion and mainly meat color and quality. But as a
result of the new EU policies, since 1997 feeding of solid feeds has become
mandatory for the veal industry. The reason for the new EU legislation was the
potential improvement in health and well being of the calves when fed diets
stimulating rumen function (Directive 97/2/EC; Directive by the Council of
Europe, 1997).
91.1.2 Replacement heifers breeding
Italy represents one of the leading countries in the herd of dairy cows.
Particularly, in the Lombardy region, the breeding of dairy cattle has a portfolio
consisting of more than 580.000 sibjects, covering a central role in the
production of almost 40% of Italian milk and participating in a major share of
the total assets of census cows (1.880.000 heads about, ISMEA, 2011).
In each single farm on the territory, the birth of female calves goes to belong to
the park of future heifers needed to restock inside the herd, as the result of the
substitution of retirement or not-producing cows.
The replacement, which presents inside the breeding an average rate of 35%
(data referred to Lombardy region; Campiotti, 2009) is a direct opportunity to
improve the genetic value of the herd, but the range of time after partum and
after weaning represents an important cost item, which in most cases does not
allow to obtain an adequate number of heifers or an adequate productive
potentiality of the same.
A proper approach to the newborn dairy calves, externalized through proper
nutrition and management, it’s the first and fundamental step for a correct
examine of the herd’s future.
1.2 Elements of physiology of nutrition in calf
The stomach of ruminants is divided into four compartments: the rumen, the
reticulum, the omasum and the abomasums. At birth the calf is considered a
functional monogatric because these structures are rudimentary and
undeveloped; particularly papillary growth, rumen wall muscularization and
vascularisation are minimal. The phase of transition from a pre-ruminant to a
ruminant is critical and can be influenced by feeding management, consequently,
it is important to know and understand the factors responsible of initiating the
cellular growth and maturation of the rumen tissues and how they can be
influenced by the composition of the diet (concentrates and roughages, Fig 1).
Moreover, specifically for veal calves, being raised at high intake levels of milk
replacer, it is also important to identify areas of potential interactions between
the milk replacer and rumen development.
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Figure 1: The progression of cellular differentiation and growth considering 3 to 35 days of life,
 in a grain fed dairy calves
Prior to transitioning from a pre-ruminant to a ruminant, growth and
development of the ruminal absorptive surface area (papillae), is necessary to
enable absorption and utilization of microbial digestion end products,
specifically rumen volatile fatty acids (VFA) (Heinrichs, 2005). These VFA (the
major are acetic, propionic, butyric, and valeric acids) are produced by naturally
occurring microbes in the rumen and are absorbed and metabolized by the
rumen epithelium (Davis and Drackley, 1998).
Presence and absorption of volatile fatty acids is indicated to stimulate rumen
epithelial metabolism and may be key in initiating rumen epithelial development,
maintaining rumen papillae growth, size and function (Baldwin and McLeod,
2000). The stimulatory effects of different volatile fatty acids are not equal, with
butyrate being most stimulatory, followed by propionate. ß-hydroxybutyrate
(BHBA) is converted from butyrate as it is oxidized by the rumen epithelial cells
and passes through the rumen wall and therefore is a measurement of rumen
epithelial metabolism (Lesmeister and Heinrichs, 2004).
11
Quigley et al. (1991) reported that blood BHBA concentrations increased when
calf starter was offered from four days of age and continued to increase
proportionately with calf starter intake. Butyrate metabolism by the epithelium
appears to increase concomitantly with decreasing rumen pH and increasing
butyrate concentrations (Baldwin and  McLeod, 2000).
A pH in the optimum range must occur for the establishment and survival of a
diverse and stable population of microorganisms. During the first few weeks of
life, rumen fermentation activity is low and pH is high. Ruminal pH is controlled
by multiple factors including relative concentration of bases, acids, and buffers
(Owens et al., 1998), the primary base in the rumen is ammonia (NH3), withlactate being the primary acid and bicarbonate and phosphate acting as major
buffers. A decrease in NH3 concentration is attributed to ruminal microbialproliferation, due to the increase of microbial use of available NH3 (Crocker et al,1998). Rumen epithelial metabolic activity may however occur independently of
volatile fatty acid production but numerous researchers have indicated that
ingestion of dry feeds and the resultant microbial end products sufficiently
stimulate rumen epithelial development (Heinrichs, 2005): it is likely that diets
composed of milk, concentrates, or forages affect the rate and extent of rumen
epithelial growth differently. Dietary and age differences have been found to
alter papillae density of the developing rumen; however, significant differences
due to dietary treatment are seldom reported for papillae density in calves,
commonly reported as the number of papillae in a fixed area (Lesmeister et al.,
2004).
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1.2.1 Liquids Feeds and Rumen Development
Milk or milk replacer is initially the primary diet of neonatal dairy calves; its
chemical composition and the shunting effect of the esophageal groove limit its
ability to stimulate rumen development. Calves receiving only milk/milk replacer
exhibit minimal rumen epithelial metabolic activity and volatile fatty acid
absorption, which once again does not increase with age. However, ruminal size
of the milk-fed calf, regardless of rumen development, has been shown to
increase proportionately with body size. Therefore, while a milk/milk replacer
diet can result in rapid and efficient growth, it does little to prepare the pre-
ruminant calf for weaning or utilization of grain and forage based diets.
Solid feeds, unlike liquid feeds, are preferentially directed to the reticulo-rumen
for digestion (Church, 1988). The intake of first stimulates rumen microbial
proliferation and production of microbial end products; however, solid feeds
have a different efficacy to stimulate rumen development based on multiple
chemical characteristics, on chemical composition (casein, starch, cellulose, and
minerals) so the resultant microbial digestion end products have the greatest
influence on epithelial development (Nocek et al., 1984). In 4 week old calves
papillae length and rumen wall thickness were significantly greater when they
were fed calf starters containing steam-flaked corn over those fed dry-rolled and
whole corn when these corn supplements made up 33% of the calf starter (Fig.2)
(Lesmeister and Heinrichs, 2004). This study showed that the type of grain
processing too can influence rumen development in young calves.
However concentrate diets with small particle size and low abrasive value
(Greenwood et al., 1997) increased volatile fatty acid production, decreased
rumen buffering capacity, and subsequently decreased rumen pH are factors
commonly associated with occurrences of parakeratosis. Abrasive value has been
defined as a feed’s efficacy in physically removing keratin and/or dead epithelial
cells from the rumen epithelium (Greenwood et al., 1997).
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Therefore, increased feed particle size, especially with forages or coarsely-ground
concentrates, maintains epithelial and papillae integrity and absorptive ability via
physical removal of the keratin layer, increased rumination and rumen motility,
increased salivary flow and buffering capacity, and development of mature
rumen function and environment.
In contrast to concentrate’s advantages for epithelial development, forages
appear to be the primary stimulators of rumen muscularization development and
increased rumen volume (Zitnan et al., 1998). Large particle size, high effective
fiber content, and increased bulk of forages or high fiber sources physically
increase rumen wall stimulation, subsequently increasing rumen motility,
muscularization, and volume (Vazquez-Anon et al., 1993; Zitnan et al., 1998).
As discussed earlier, increases in rumen muscularization and volume have
occurred independently of epithelial development.
Figure 2: External and internal appearance of a 4 week-old calf rumen
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Figure 3: Age 4 weeks - Diet: milk and grain.
Figure 4: Age 12 weeks - Diet: milk and hay.
The rumen of the calf at 4 weeks of age is more developed than the 12-week-old calf that received no
grain (Pictures from: PennState University On-Line Web Site)
15
Figure 5: Age 6 weeks - Diet: milk and grain.
Figure 6: Age 8 weeks - Diet: milk and grain.
In the figures (Figures 2-6) the rumen of the calf at four  weeks of age is more developed than the 12-
week-old calf that received no grain . Continued grain feeding through 6 or 8 weeks leads to further
papillae growth and development. Since grain intake is strongly related to rumen development and
since we normally cannot see the inside of calves' rumens, grain intake can be used as an indirect
estimator of rumen development and a criterion for weaning. (Pictures from PennState Univesity).
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1.3 Critical points of veal and replacement heifers breeding
The veal calves are particularly susceptible to stress syndromes, caused by
environmental conditions and management. Moreover, the coverage of colostral
antibodies is extremely variable. The physiologic immunodeficiency affect both
the innate immune system an the adaptive system into its components humoral
and cell-mediated immunity. These negative phenomena are added to
mismanagement and lack of oversight of the animal health status that cause
increased sensitivity to the disease in these so delicate stages and can be formed
as the farm of origin, as the final step into the breeding of livestock. The farms
of origin are often represented by herds of dairy cows, in which calves are not
included in business plans (especially males or females in excess) and are almost
considered as a by-product, which results in an uncorrected management of their
first days of life. The move by the breeding to rise to one in which the animals
will complete the production cycle, is another critical point in their management
and the calves often suffer a transport too early, on the timing of umbilical
wound healing: in this regard, the Regulation (EC) n. 1/2005 laying down rules
for the transport of live animals, states that can not be handled calves under 10
days of age. The situation may be exacerbated by unfavourable environmental
conditions on the fattening farms, where they are inevitably conveyed animals of
various origin and therefore with a highly differentiated profile of colostrum
immunity, determining a risk of multiple cross-contamination.
In the fattening companies the health status is a particularly critical factor and
results in an economic loss, not only for the eventual death of the animal but
also as regards the additional costs antibiotic treatments and the reduction of the
growth of the animals.
The onset of health problems can’t be often attributed to specific etiologic
agents but to multiple factors such as the type of farming and facilities, the
competence of the operators,. Therefore, many of the diseases found in the
modern manufacturing units in intensive nature are classified as diseases
influenced by environmental factors and/or managerial act as stressors. The
action of these stressors may be limited in time or, in the worst case and in the
absence of corrective measures, last for the entire life of the animal.
Maier and Watkins (1998) proposed a close relationship between stress and
immune function: the immunological changes due to stress are similar to those
induced by infection. In this context, the immune response, stress and the
inflammatory process are a set of responses activated by the body to neutralize
the stimuli that alter homeostasis (Ottaviani, 1998).
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In dairy farm context, for the proper management of the future heifers is
essential a correct management of the newborn from the first moments of life
which presupposes a proper process management, food and health, as well as an
adequate structural support.
Nutrition and management of young calves is in-fact a key parameter for their
health and profitability of dairy, but together with the management issues that
frequently needed, infectious agents and environmental stressors are able to
interact with the animal causing greater susceptibility to pathogens of the same,
with particularly evident during the delicate period of weaning.
Recent results from studies on 80 farms in the Lombardy region show that the
average mortality in the first month of life of replacement heifers is around 15%,
with a mortality rate of 8.9% at delivery (ideally <5%) and 6.4% after the first
month of life (Aral, 2003).
Studies carried out by Huzzey and Overton (2010) have also revealed the need to
monitor on dairy cows the trend over time (in particular during the transition
phase) of stress indicators as predictors of metabolic diseases and immune
deficiencies (in particular the endogenous cortisol): it is therefore of primary
importance to correlate the status of maternal health with that of the calf in the
immediate post-partum period. It has been shown how the environmental
stressors in cattle induce an increase in acute phase proteins such as haptoglobin
and serum amyloid A protein (Arthington et al., 2003; Lomborg et al., 2008): in
addition to cortisol is therefore important to monitor the status of these
indicators. The study of strategies that impose a nutritional and managerial
stricness becomes crucial.
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1.4 Diseases of the newborn calf
Rate of calf illness and mortality vary considerably among individual farms,
depending on the calf management program. Calfhood diseases have a
significant financial impact on dairies. The costs associated with calfhood disease
include treatment costs, replacement costs, genetic loss, and impaired future
performance.
1.4.1 Intestinal disease
Neonatal diarrhoea, or scours, accounts for between 50 and 75 % of deaths in
dairy calves under three weeks of age. The cause is often multi-factorial and
includes exposure to one or more infectious agents (Tab.1) as well as
management and environmental factors including colostral management,
sanitation, housing, grouping strategies, ventilation, stress, and nutrition.
Infectious agents live for long periods in the environment, the major route of
infection for most of these agents is from contact with infective faeces in the
environment, or ingestion of faecally-contaminated feed or water.
Infectious agents or their toxins cause damage and inflammation in the lining of
the small and/or large intestine. This results in an increase in the secretion of
fluids and electrolytes into the intestine, an impaired ability of the intestine to
reabsorb fluids and electrolytes, and an impaired ability to digest and absorb
nutrients. The calf can lose blood, water, electrolytes, and nutrients such as
proteins and sugars in the scours. Severe diarrhoea leads to rapid dehydration
and often death since the most common cause of death in scouring calves is
dehydration.
Many of the infectious agents that cause diarrhoea in calves can also cause
disease in humans (e.g. E. coli, Salmonellosis, Cryptosporidiosis).
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1.4.2 Septicemia
Septicemia often occurs during the first week of life and is defined as the
presence of bacteria and their toxins in the bloodstream. While often caused by
E. coli (septicemic colibacillosis), many other bacteria including Salmonella sp. or
Mycoplasma bovis may also be involved. These bacteria may enter the bloodstream
by crossing a damaged intestinal wall or through the open navel of the newborn
calf. These bacteria may travel through the blood to infect other organs
including the brain (meningitis), heart, lungs, liver, kidneys, eyes, or joints.
1.4.3 Cryptosporidiosis
Cryptospotidium is a protozoan parasite. After ingestion it adheres to the lining of
the intestine wall and causes damage to the microvilli,  the finger-like projections
that are important for absorption of water and nutrients. There is no effective
treatment that works directly against cryptosporidiosis. Both coccidia and
cryptosporidia are resistant to antimicrobials. Additionally, cryptosporidium is highly
resistant to most disinfectants.
Infectious Agent Age of affected calves Transmission
Bacteria
Escherichia coli Usually less than 3 to 5 days F/O
Salmonella typhimurium Usually 2 to 6 weeks F/O + C/M+ S/N
Clostridium perfringens C Usually 5 to10 days F/O
Viruses
Rotavirus Usually 7 to 14 days F/O
Coronavirus Few days to several weeks F/O
Bovine virus diarrhea Any age F/O + C/M +S/N
Protozoal Parasites
Coccidiosis From 17 days to 6 months F/O
Cryptosporidium Usually 5 to 35 days F/O
Table 1: Main gastrointestinal infectious agents and their methods of  transmission (F/O= faecal/oral;
C/M=colostrum/milk; S/N= Salival/Nasal)
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1.4.4 Pneumonia
Pneumonia is an infection that causes inflammation and damage to the calf’s
lungs, and is the second most common health problem for young calves. While
this commonly occurs around 4 or 5 weeks of age, it can also occur in younger
and older calves. Although the infection is caused by bacteria and viruses, the
calf’s environment and management are also very important factors in causing
the disease. Humid, moist air, drafts, exposure to wet or chilling cold conditions,
and sudden temperature swings are risk factors for pneumonia. Build-up of
ammonia and other gases in confinement housing irritate the calf’s respiratory
tract, damaging its defense mechanisms against infection. Other stressors that
increase the calf’s risk for pneumonia include crowding, transportation, weaning,
and exposure to infectious agents through the co-mingling of calves in group
pens or by housing of calves with older animals. Thus, pneumonia is caused as
much by poor environment and management as it is by exposure to infectious
agents.
Bacterial respiratory pathogens include Pasteurella multocida, Pasteurella hemolytica,
Corynebacterium pyogenes, Mycoplasma dispar, and Hemophilus somnus.  Viral respiratory
pathogens include Infectious Bovine Rhinotracheitis (IBR), Parainfluenza-3 virus (PI-3),
Bovine Respiratory Syncitial Virus (BRSV), and Bovine Virus Diarrhoea (BVD).
1.4.5 Preventing the introduction and spread of disease
Biosecurity is essential in calf health management. This involves increasing calf’s
level of immunity against disease while decreasing the calf’s contact with
infectious agents. Improving a calf’s disease resistance requires proper colostrum
management, a quality nutrition and vaccination program, and minimizing
environmental and other stressors. Minimizing the risk of exposure to pathogens
considers environmental management, housing, grouping of animals, sanitation,
and control of potential carriers of disease such as people, animals or equipment.
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1.5 Feed Additives
The first goal of the livestock production is the delivery of safe foods for human
consumption taking into account to welfare of the animal and respect of the
environment. In the past, antibiotics have been included in animal feed at sub-
therapeutic levels, acting as growth promoters (Dibner and Richards, 2005).
The transference of antibiotic resistance genes from animal to human microbiota
lead to banning the use of antibiotics as growth promoters in the European
Union since 1st January 2006.
There is need to look for viable alternatives that could enhance the natural
defence mechanism of animals and reduce the massive use of antibiotics (Gaggia
et al., 2010) and into this contest the use of feed additives has been an important
part.
The additives are mainly used in animal nutrition to improve the quality of feed
and the animals’ performance and health, and consequently to guarantee the
safety of animal origin food.
According to Regulation (EC) No 1831/2003 and No 767/2009, feed additives
may not be put on the market unless authorization, following a scientific
evaluation demonstrating that the additive has no harmful effects, on human and
animal health and on the environment. The European Food Safety Authority
(EFSA) is responsible for conducting the evaluation of the data submitted
requesting authorisations that are granted for specific animal species, specific
conditions of use and for ten years periods.
The additive can be a technological additive, which influences the technological
aspects of the feed but not directly influences the nutritional value of the feed
(e.g. preservatives, antioxidants, emulsifiers, stabilizing agents, acidity regulators,
silage additives); a sensory additive, which improve the palatability of a diet by
stimulating appetite (e.g. flavours, colorants); a nutritional additive which supply
specific nutrient required by the animals (e.g. vitamins, minerals, amino acids,
trace elements); a zootechnical additive which improve the nutrient status of the
animal enabling more efficient use of the nutrients present in the diet (e.g.
digestibility enhancers, gut flora stabilizers) or it can be a coccidiostats or
histomonostats, used to control intestinal health of poultry through direct effects
on the parasitic organism concerned.
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1.6 Probiotics
Probiotics are feed additives containing microbial species that are considered to
be non-pathogenic normal flora. They are also referred to as “direct-fed
microbials” and many definitions have been proposed for the term “probiotic”.
The more widely accepted one is “live microorganism which, when administered
in adequate amounts, confer a health benefit on the host (FAO/WHO, 2002).
The expected characteristics and safety criteria of probiotics are:
 Non-toxic and non-pathogenic
 Accurate taxonomic identiﬁcation
 Normal inhabitant of the targeted species
Survival, colonization and being metabolically active in the targeted site,
which implies:
 Resistance to gastric juice and bile
 Persistence in the gastro intestinal tract
 Adhesion to epithelium or mucus
 Competition with the resident microbiota
 Production of antimicrobial substances
 Antagonism towards pathogenic bacteria
 Modulation of immune responses
 Ability to exert at least one scientiﬁcally-supported health-promoting
properties
 Genetically stability
 Amenability of the strain and stability of the desired characteristics
during processing, storage and delivery
 Viability at high populations
 Desirable organoleptic and technological properties when included in
industrial processes
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1.6.1 History and legal basis in the EU on probiotics in feed
All additives used in animal feed, including yeasts and bacteria, are strictly
regulated within the EU legislative framework.
The microbial feed additives were covered by the Council Directive
70/524/EEC concerning additives in feeding stuffs. The Directive was amended
a lot of times, the last one was by the Council Directive 96/51/EC. In 2003,
these Directives were repealed by the new Regulation (EC) No. 1831/ 2003 of
the European Parliament and of the Council on additives for use in animal
nutrition which sets out the rules for its authorisation, use, monitoring, labelling
and packaging. In the Regulation (EC) No. 1831/2003, the micro-organisms re
included in the category ‘zootechnical additives’ and as functional group within
the ‘gut microflora stabilisers’ defined as micro-organisms or other chemically
defined substances, which, when fed to animals, have a positive effect on the gut
microflora. Under this Regulation, specific labelling requirements are needed for
micro-organisms such as the expire data of the guarantee or storage life from the
data of manufacture, the directions for use, the strain identification number, and
the number of CFU per gram. In the EU, there is a positive list of the micro-
organisms to be included in market products; this list contains some columns
which describe the following specifications:
 EU number
 additive
 chemical formula, description
 species or category of animal
 maximum age
 minimum content (colony forming units per kilogram, cfu/kg) in the
complete feeding stuffs
 maximum content (cfu/kg) in the complete feeding stuffs
 other provisions
 period of authorisation.
With respect to the guidelines for the assessment of micro-organisms, the
Council Directive 87/153/EEC established the composition of the submission
dossier for all feed additives. The Commission has updated these guidelines in
1994 introducing specific requirements for enzymes and microorganisms
(Commission Directive 94/40/EC).
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In 2001, the Directive 87/153/EEC was amended by the Commission Directive
2001/79/EC. Until may 2003, the risk assessment of animal feed additives in
Europe was the responsibility of the Scientific Committee of Animal Nutrition
(SCAN) (Anadòn et al., 2006). After this date, the European Food Safety
Authority (EFSA) took over the functions of SCAN. While EFSA provide
expert scientific advice to the European Commission the approval and risk
management of a probiotic product is responsibility of the EC and its
constituent member’s states.
The requirements for a novel probiotic product required by EU regulations on
animal feed additives are the identification and characterization to species level,
and the efficacy data must be provided in support of any claims made for the
product. Some characteristics are requested to product such as no adverse
effects on the health of performance, the product must be safe for the operator,
have no adverse effects upon exposure and also the product  must not pose a
risk to the safety of the end-consumer (SCAN, 2001).
Signiﬁcant progress in legislation for the safety evaluation of probiotics has been
made. The European Food Safety Authority (EFSA) has introduced the concept
of Qualiﬁed Presumption of Safety (QPS) that provides a generic assessment
system for use within EFSA that in principle can be applied to all requests
received for the safety assessments of microorganisms deliberately introduced
into the food chain (EFSA, 2005). According to recent evaluation (Wassenaar
and Klein, 2008), QPS system appears more ﬂexible because it takes into
account additional criteria to evaluate the safety of bacterial additives such as a
history of safe use the food industry and the acquisition of antibiotic resistance
or virulence determinants. EFSA has published a list of microorganism, which
possess a known historical safety, proposed for QPS status (EFSA, 2007).
Micro-organisms used in animal feed in the European Union (EU) are mainly
bacterial strains of Gram-positive bacteria belonging to the types Bacillus (B. cereus
var. toyoi, B. licheniformis, B. subtilis), Enterococcus (E. faecium), Lactobacillus (L.
acidophilus, L. casei, L. farciminis, L. plantarum, L. rhamnosus), Pediococcus (P. acidilactici),
Streptococcus (S. infantarius); some others probiotics are microscopic fungi such as
strains of yeast belonging to the Saccharomyces cerevisiae species and kluyveromyces.
The list does not include Enterococcus species, even if E. faecium shows a long
history of apparent safe use in food or feed. The main reason is due to the
possibility of carrying transmissible resistance to antibiotics by Enterococcus spp.
(EFSA, 2007). Often not valid taxonomic designations are used in scientiﬁc
publications or in commercial preparations. Lactobacillus, Enterococcus, Bacillus and
Saccharomyces are actually the most used probiotics in livestock and poultry.
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Many studies indicate that the organisms cited on the labels of certain probiotic
products are not actually contained within the product and often the products
contain other species than those claimed on the label (Huff, 2004; Mattarelli et
al., 2002; Wannaprasat et al., 2009) It is necessary to indicate clearly on the label
of the products the name of the exact taxonomic species of probiotics utilized in
order to avoid confusion and misidentiﬁcation. Regulatory bodies should
carefully monitor and control these indications. Another important point is the
viability and consequently derived concentrations of viable bacteria of probiotic
preparations at the moment of administration to the animals.
The claim made by the producer about the preparation should reﬂect the actual
composition of the food until the “best-before” date of the product at the
recommended storage conditions with a decrease of one or two logarithmic units
at maximum (Czinn and Blanchard, 2009); often the number of probiotic
bacteria found in the products were below the one declared or they were absent
(Wannaprasat et al., 2009). It is fundamental to study proper formulations which
will allow the maximum viability of the utilized bacteria species.
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Table 2: List of probiotics studied for application in animal feed
Genus Species
Bifidobacterium B animalis subsp. animalis (B. animalis)
B. lactis subsp. lactis (B. lactis)
B. longum subsp. longum(B. longum
B. pseudolongum subsp. pseudolongum
B. thermophilum
Enterococcus E. faecalis (Streptococcus faecalis
E. faecium (Streptococcus faecium
Lactobacillus L. acidophilus
L. amylovorus
L. brevis
L. casei subsp. casei (L. casei)
L. crispatus
L. farmicinis
L. fermentum
L. murinus
L. plantarum subsp. plantarum (L. plantarum )
L. reuteri
L. rhamnosus
L. salivarius
L. amylovorus (L. sobrius)
Lactococcus L. lactis subsp. cremoris (Streptococcus cremoris)
L. lactis subsp. Lactis
Leuconostoc L. citreum
L. lactis
L. mesenteroides
Pediococcus P. acidilactici
P. pentosaceus subsp. Pentosaceous
Propionibacterium P. freudenreichi
Streptococcus S. infantarius
S. salivarius subsp. Salivarius
S. thermophilus (S. salivarius subsp. thermophilus)
Bacillus B. cereus (B. cereus var. toyoi)
B. licheniformi
B. subtilis
Saccharomyces S. cerevisiae (S. boulardii)
S. pastorianus (S. carlsbergensis)
Kluyveromyces K. fragili
K. marxianus
Aspergyllus A. oriza
A. niger
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1.6.2 Gut microbiota
In last 15 years the use of probiotics strains in animal production has been
increased. These probiotics strains can modulate the balance and activities of the
gastrointestinal microbiota in which are responsible to gut homeostasis. The
intake of probiotics supplemented in ration and provided to the animals, can
strongly affect the structure and activities of the gut microbial communities
leading to promoting health and improving the performance in livestock, when it
is impaired by numerous factors, such as dietary and management constraints.
The understanding of the digestive ecosystems in terms of microbial
composition and functional diversity is fundamental to modulate the
gastrointestinal tract (GIT) of domestic animals providing to them the possibility
to maintain the homeostasis of these complex microbial communities, which can
be composed of bacteria, protozoa, fungi, archaea, and viruses, thus promoting a
reduction of the incidence of diseases. Therefore considerable researches during
30 years are characterizing the domestic animals´GIT. The welfare, health and
feed efficiency of the animals can be affected by different factors, many of them,
environmental factors. Among these factors, feeding practices, composition of
animal diets, farms management and productivity constraints can influence the
microbial balance in GIT, whose role is fundamental to gut homeostasis and its
reduction consequently can affect efficiency digestive When occurs the reduction
of microbial in GIT, some reactions as digestion and fermentation of plant
polymers are impaired, since the action of the microbiota on gut is strongly
related with the realization these reactions, and the animals also are impaired by
the fact these polymers to be of particular importance to the herbivorous
(Chaucheyras-Durand and Durand, 2010).
Under normal circumstances, commensal bacteria are an essential health asset
with a nutritional function and a protective inﬂuence on the intestinal structure
and homeostasis. The intestinal microbiota protects against infections, and
actively exchanges developmental and regulatory signals with the host that
primes and instructs mucosal immunity. Although the intestinal microbiota is
complex and the role of most of the bacteria in providing beneﬁt to the host is
not clear, bacterial species of the genera Lactobacillus and Biﬁdobacterium have been
shown to supply protection against enteric infections. By enhancing the
beneﬁcial components of the gut microbiotas it is possible to treat various
intestinal disorders and maintain host well-being (O'Hara and Shanahan, 2007).
Moreover, access to beneﬁcial microorganisms has been suggested to be one of
the selective advantages of social behaviour in animals (Ley et al., 2008). In
particular, the close proximity of individuals in livestock or poultry farms could
facilitate the host–host transmission of microbiota.
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Therefore, in high population density, it is important to maintain a “healthy”
microbiota as a barrier against pathogen infection. A key issue is to identify and
know the species present in the gut microbiota of the different animals. Studies
on the survey of the gut bacterial communities in 60 species of mammals based
on 16S rRNAanalysis showed that diet, host phylogeny and gut morphology
inﬂuence the microbial ecology of the gastrointestinal tract (Ley et al., 2008). If
mammals are classiﬁed as monogastric and polygastric, their microbiota clusters
into groups that correspond to these categories. However, the composition of
the faecal microbiota is also a strong predictor of the host physiology status. The
major microbial groups in monogastric animals (such as pig, chicken, rabbit and
man) are Bacteroides, Clostridium, Biﬁdobacterium, Eubacterium, Lactobacillus,
Enterobacteriaceae, Streptococcus, Fusobacterium, Peptostreptococcus and Propionibacterium.
In polygastric animals, (such as cow, sheep and lamb), the rumen is the most
important microbial ecosystem with the predominance of ﬁber-degrading groups
belonging to Fibrobacter, Ruminococcus, Butyrivibrio and Bacteroides together with
major groups such as Prevotella, Selenomonas, Streptococcus, Lactobacillus and
Megasphaera. Some anaerobic fungi and ciliate protozoa and a large number of
methanogens are also present in the rumen (Mackie et al., 2000). In mammals,
the percentage of the different microbial groups varies between individuals,
depending on age (Mueller et al., 2006) and on the health/pathological status
(Abt and Artis, 2009). Diet is an additional factor inﬂuencing the gut microbiota;
herbivores contain a higher number of bacterial phyla, while carnivores the
fewest number, and omnivores are at an intermediate level (Ley et al., 2008).
1.6.3 Efﬁcacy of probiotics
The use of probiotics in animal feeding could be enhanced by a preliminary in
vitro screening: antimicrobial activity, survival in the GIT, adhesion studies and
antibiotic susceptibility are among the main probiotic properties that should be
analysed to assess functionality and safety. The advanced molecular methods,
such as microarrays, will improve the detection of these multiple characteristics,
also allowing the analysis of phenotypic and genetic properties useful for
industrial production.
Probiotic activity could be related to genera, species, or strains. An approach in
probiotic application could be the use of mixtures of strains belonging to
different genera or species (Timmerman et al., 2004).
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Dose, timing and duration of the administration of probiotics may be a factor
affecting efﬁcacy: in acute infectious diarrhoea, higher dose of probiotic given
for short period of time seems to be more effective than lower doses (Sazawal et
al., 2006).
Another determinant may be the age of the animals; during early life,
colonization patterns are instable and newborn animals are then susceptible to
environmental pathogens. Initial colonization is of great importance to the host
because the bacteria can modulate expression of genes in epithelial cells thus
creating a favorable habitat for themselves (Siggers et al., 2007)
1.6.4 Probiotics and immune modulation
The maturation of the humoral immune mechanisms can be conducted by
microbial colonization, this events can promote the circulation of the IgA and
IgM secreting cells.
The other important factor that can be affected by microbial colonization on the
gut of different animals particularly the ruminants are the balance of the
different T helper subsets. The memory B and T cells migrate to effectors sites
in consequence these events. Other mechanisms to immune modulation are
followed by active proliferation local induction of certain cytokines and
production of secretion antibodies as IgA (Perdigon et al., 1999; Al-Saiady et al.,
2010). When the host is exposure to the antigen, immune cells respond releasing
cytokines from host direct the subsequent immune responses. The low-dose
tolerance immunity TGF-B associated in via local cytokine is the man
mechanisms which the gut associated lymphoid tissue maintains homeostasis.
Some lactic acid bacteria can induces the production of proinflammatory
cytokines, tumor necrosis factors alpha and interleukin-6 from human peripheral
blood mononuclear cells. A strain of Lactobacillus casei can inhibit the growth of
pathogenic strains as Pseudomonas aeruginosa and Listeria monocytogenes leading to an
increase in the level of macrophages (Fleige et al., 2008; Frizzo et al., 2010;
Buddington et al., 2011). Others strains as Lactobacillus acidophilus and
Bifidobacterium bifidum could inhance non-specific immunity and concluded that
specific lactic acid bacteria could play a role in specific age groups, specific
neonates or the elderly (Fleige et al., 2008).
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1.6.5 Probiotics in dairy cows and cattle
Studies on the application of probiotics in ruminants have been performed
considering both the health status of the animals and the economics parameters.
The most significant effects of probiotics have been demonstrated when they
have been included in the diet of animals during particularly stressful: at weaning,
at the beginning of lactation period and after a dietary shift.
In adult ruminants, probiotics have mostly been selected to target the rumen
compartment, which ecosystem consists of wide diversity strictly anaerobic
bacteria, ciliate protozoa, anaerobic fungi and archea. Regarding bacterial
probiotics, lactate-producing bacteria (Enterococcus, Lactobacillus) which would
sustain a constant level of lactic acid, thus allowing the lactate-utilising species to
flourish (Nocek et al., 2002; Nocek and Kautz, 2006) may represent a possible
means to limit acidosis in high-concentrate fed animals. Megasphaera elsdenii or
Propionibacterium spp., which utilise lactate as an energy source, could be
administere as direct-fed microbials to avoid ruminal lactate engorgement
(Klieve et al., 2003; Stein et al., 2006). A growing interest for using probiotics is
to reduce digestive carriage by adult ruminants of human pathogens, such as
Escherichia coli O157 or Salmonella. Among zoonotic pathogens, E.coli O157:H17
is the main health threat for ruminants, and cattle are considered the major
reservoir (Lejeune and Wetzel, 2007), playin an important role in epidemiology
of human infections (Griffin and Tauxe, 1991). To reduce carriage shedding of
this coliform strain have been successfully applied to adult cattle (Schamberger
and Diez-Gonzalez, 2002). Certain strain of Lactobacillus acidophilus have shown to
decrease numbers of E.coli O157 in feedlot cattle faeces (Tabe et al., 2008) and
also appear to reduce shedding of Salmonella enterica (Stephens et al., 2007). In
particular, steers fed a diet containing Lactobacillus acidophilus NP51 showed a
reduction of E.coli O157 faecal shedding  by 57% (Younts-Dahl et al., 2004) and
by 35% in beef cattle (Peterson et al., 2007). Other autors have found greater
reductions (Brachears et al., 2003; Tabe et al., 2008).
In dairy cow, the yeast strain supplementation have been shown to improve
performance, the most consistent effects being an increase in dry matter intake
and milk production (Jouany, 2006; Stella et al., 2007; Desnoyers at al., 2009).
Other benefits have been related to greater total culturable ruminal bacterial
population densities and cellulolytic microorganism (Chaucheyras-Durand et al.,
2008) and increase fiber digestibility (Guedes et al., 2008; Marden et al., 2008).
The study of Krehbiel et al. (2003) too suggest that probiotics fed alone or in
combination with fungal cultures might be efﬁcacious for increasing milk
production by lactating dairy cows.
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In beef cattle, undergo a variety of stresses, such as recent weaning, transport,
fasting, assembly, vaccination, castration, and dehorning the probiotics
potentially increase some growth parameters when fed to finishing cattle
(Krehbiel et al., 2003), not consistent in other studies (Younts-Dahl et al., 2005;
Peterson et al., 2007; Vasconcelos et al., 2008).
The greatest performance response to the bacterial probiotic generally occurred
within the ﬁrst 14 d of the receiving period (Krehbiel et al., 2003).
1.6.6 Probiotic in calves
 Bacterial microflora population in newborn calves
The colonization of newborn’s gastrointestinal tracts starts during the delivery
and it is initially strongly influenced by the manner and environment of birth, by
the diet, use of antibiotics, genetic background and environment of the
individual. Bifidobacterial population have been detected as part of this complex
ecosystem where they may provide health-promoting benefits to the host
(Vlkovà et al., 2006). Generally, bacteria colonization starts with E.coli detectable
in all areas of the digestive tract of calves eight hours after birth, lactobacilli and
streptococci being detectable after one day of life. In healthy animals, lactobacilli
quickly colonize the gut (Smith, 1965; Karney et al., 1986). Microbial
colonization of the rumen occurs rapidly after birth, with a large population of
strictly anaerobic bacteria presents after two days (Fonty et al., 1987). Although
bifidobacteria were often isolated from calf feces (Scardovi, 1986), only a scarce
information exists on their occurrence and quantity in calf gut and no data were
available about bifidobacterial  counts in other parts of the gastrointestinal tract
of young animals.
 Use of probiotics in newborn calves
In the neonate and in stressed calves, the microbial population is in transition
and extremely sensitive; abrupt changes in diet or the environment can cause
alterations in microbial populations in the gastrointestinal tract. Neonatal-calf
diarrhoea, most often caused by enterotoxigenic E.coli, is an important cause of
morbidity and mortality in young ruminants. Moreover, faecal counts of
lactobacilli normally are higher than coliforms in healthy animals and reversed in
those suffering from diarrhea.
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Feeding probiotics to suckling calves has shown to improve digestion with
beneﬁcial actions on gut health: the rate, the severity and length of diarrhoeal
episodes are reduced (Lejeune and Wetzel., 2007; Morrison et al., 2010; Riddel et
al., 2010). The decreased incidence of diarrhea might be associated with a
consistently increased shedding of Lactobacillus (Abu-Tarboush et al., 1996) and
an inconsistent decreased shedding of coliforms (Krehbiel et al., 2003) in feces in
response to supplements of Lactobacillus.
Consequently to the positive response on gut and general health (Fleige et al.,
2008; Al-Saiady et al., 2010; Frizzo et al., 2010), the effect of probiotic on growth
performance is investigated (Timmerman et al., 2005; Frizzo et al., 2010;
Morrison et al., 2010; Riddel et al., 2010). Improved weight gain and rumen
development have been reported in young calves with several bacterial and yeast
strain supplementation (Mokhber et al., 2007 Adams et al., 2008; Frizzo et al.,
2008; Kawakami et al., 2010; Nagashima et al., 2010; Frizzo et al., 2011).
To select the most effective and speciﬁc potential probiotic for veal calves, the
identiﬁcation at the clonal level of the calves’ microbiota is crucial, since
different strains within the same species may have different probiotic properties
(Soto et al., 2010, Xiao-Hua et al., 2010; Ripamonti et al., 2011). The strains
naturally residing in the digestive system of veal calves can provide protection
against gastrointestinal infections. In addition, it has been recognised that
functionality of multistrain and multispecies probiotics could be more effective
than that of monostrain probiotics (Sanders et al., 2003; Hong et al., 2005;
Timmerman et al., 2005; Gavini et al., 2006; Corcionivoschi et al., 2010). The
advantages of administering multistrain and multispecies probiotics include the
enhanced capability of colonizing the gastrointestinal tract and to combine the
different mechanisms of action of each strain in a synergistic way.
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1.7 Acidifiers in animal production
According to Regulation (EC) No 1831/2003 and No 767/2009, only additives
that have been through an authorization procedure may be placed on the market.
In European Union organic acids such as formic, propionic and several others
(lactic, citric, fumaric and sorbic acids) as well as their salts (e.g., calcium
formate, calcium propionate) are considered technological additives which influences
the technological aspects of the feed. This does not directly influence the
nutritional value of the feed but may do indirectly by improving its handling or
hygiene characteristics.
Organic acids are weak acids with at least one carboxylic group (-COOH) and a
carbon chain having not more than 10 C–atoms, normally C1 to C7. This
distinguishes them from the fatty acids with longer carbon chains (Theron and
Lues 2007).
Acidifiers have been used for decades in commercial compound feeds, mostly
for feed preservation (Ricke, 2003), for which formic and propionic acids are
particularly effective. Moreover acidification of milk replacers for use in rearing
young calves has been widely practiced and tested in Europe  (Jaster et al., 1990).
Actually the market for organic acids in Europe is expected to continue to grow,
in Northern Europe was already beginning to adopt these products before the
EU ban of antibiotics like growth promoter, based on the expectation that acids
would emerge as a ‘cost-effective, performance enhancing option for feed
industry’ (Kochannek, 2011).
The salts of organic acids have the advantage of being less corrosive, less
odorous and easier to handle than free acids. Another rather new form used in
animal nutrition is coated acids: the coating allows a stepwise release of the acid
so that it can pass through the small intestine and also act directly in the large
intestine (Piva et al., 1997; Piva et al., 2002). Factors influencing the decision of
which acid to use in animal nutrition, its form and its dosage depends on the
efficacy but also on the costs which can vary considerably among the different
commercially available organic acids.
The main mode of action of organic acids is through their antimicrobial effects
enhancing the growth performance, the magnitude of which is dependent on the
chemical properties of the individual acid or acid salt.
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1.7.1 Use of acidifying in livestock
Benefits from the use of dietary acidifiers include positive effects on growth
performance and health status (Tab.3).
Effective Form Effects
Feed H+
H+ and anion
-pH reduction
-reduction of acid binding capacity
-reduction of microbial growth
-antibacterial effects
Intestinal Tract H+
Anion
H+ and anion
-pH reduction in stomach and duodenum
-improved pepsin activity
-complexing agents for cations
-antibacterial effects
-change in microbial concentrations
Metabolism -energy supply
Table 3: The different uses of acidificants in livestock, and their main effects (Lückstäd, 2006)
1.7.2 Acidified milk/milk replacers
Acidifying of milk has some main reasons: conservation of the milk, killing
pathogens inside it and destruction of some antibiotics, but also as a way of
reducing the pH in the calves digestive tract and thereby prevent diarrhoea
caused by bacteria like E. coli (Jaster et al., 1990). The acidification can be caused
by adding to cold milk (10°C) organic acids like formic acid, propionic acid or
citric acid (Davis and Drackley, 1998), added carefully and mixed properly in
order to achieve a homogenous liquid. Davis and Drackley (1998), reported an
improvement in the performance of calves fed acidified milk, but other studies
show no advantage to calf growth (Jaster et al., 1990; Raeth-Knight et al., 2009).
The acidified milk should ideally have a pH of >5.0 in order to impair the
growth of E.coli (Cherrington et al., 2008; Constable, 2009) and for stable
preservation (Tomkins and Jaster, 1991).
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1.7.3 Growth promoting effects
Organic acids may influence mucosal morphologhy or induce alterations in gut
microflora thought bacteriostatic or bactericidal actions, as well as enhance
endogenous enzyme activity, stimulate pancreatic secretions and they also serve
as substrates in intermediary metabolism (Partanen and Mroz, 1999). It is also
hypothesized that acidifiers could be related to the reduction of gastric emptying
rate, the energy source in intestine, the chelation of minerals, the stimulation of
digestive enzymes and the provision of an energy source in the distal
gastointestinal tract. Organic acid supplementation can reduce dietary buffering
capacity, which is expected to slow down the proliferation and/or colonization
of undesirable microbes, e.g. Escherichia coli, in the gastro-ileal region, resulting in
reduction of scouring (Partanen and Mroz, 1999; Partanen, 2001).
In general it is believed that acidifiers can enhance the growth performance by:
a. Improving gut health by promoting the beneficial bacterial growth,
while inhibiting growth of pathogenic microbes (through reduction of pH
and buffering capacity of diets). A reduced buffering capacity of diets
containing organic acids is also expected to slow down the proliferation
and/or colonization of undesirable microbes, e.g. E. coli, clostridia in the
gastro-ileal region (jejunum, cecum) (Partanen and Mroz, 1999; Biagi et al.,
2003). In addition organic acids or their salts could not improve the
animal growth performance, but they could indirectly increase cecal pH
and cecal ammonia concentrations (Biagi et al., 2007).
b. Stimulating - improving pancreatic secretions (Harada et al., 1986),
which increase the digestibility, absorption and retention of protein and
amino acids (Blank et al.,  1999, Kemme et al., 1999) and minerals (such as
Ca, P, Mg and Zn - particularly Ca and P) (Jongbloed et al., 2000; Valencia,
2002; Omogbenigun et al., 2003) in the diet. Although opposite results
have also been reported (Radecki et al., 1988), it is generally considered
that dietary organic acids or their salts lower gastric pH, resulting in
increased activity of proteolytic enzymes and gastric retention time.
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c. Influencing of gut morphology by promoting changes in the digestive
function and microbial ecology and fermentation (Piva et al., 2002;
Manzanilla et al., 2004). Some organic acids act positively on microbial
growth and ammonia production by pig cecal microflora. Kirchgessner
and Roth (1998), have proposed that organic acids may stimulate
intermediary metabolism resulting in improved energy or protein/amino
acid utilization. The use of some organic acids has been found to reduce
the formation of biogenic amines (such as cadaverine and putrescin) that
have unfavourable effects on growth and feed conversion. The growth
stimulation effects of formic, acetic and propionic acids are partly caused
by their inhibitory effect on biogenic amines (Eckel et al., 1992).
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1.7.4 Mechanism of action
 The acid-buffering capacity
Addition of organic acids reduces dietary pH curvili nearly depending on the
acid pKa value and buffering capacity (Bolduan et al. 1988) of the diet. The pH-
lowering effect of different organic acids is reduced in the following order:
tartaric acid>citricacid>malic acid> fumaric acid>lactic and formic acids>acetic
acid> propionic acid. Salts of organic acids have only a small influence on
dietary pH, but the addition of protein and mineral sources to the diet weakens
the pH-lowering effect of the acid (Roth and Kirchgessner, 1998). It seems
reasonable to assume that the buffering capacity of feed can be considerably
influenced by the selection of feed ingredients, and it may in part reflect the
differences in the effectiveness of acidifiers.
In general, organic acids lower dietary buffering capacity, whereas certain salts of
organic acids can increase it. The greatest acidification benefits have been
observed in diets formulated from cereals and plant proteins, while the growth-
promoting effect in diets containing milk products is small (Giesting et al., 1991).
The latter presumably holds true when lactose in milk products is converted to
lactic acid by lactobacilli in the stomach, creating the desired reduction in pH
and thus reducing the need for diet acidification (Easter, 1988).
 The antimicrobial activity
The reduction of pH due to inclusion of organic acids conducts to an
antimicrobial effect can prevent the growth of bacteria (especially Gram negative
bacterial species, like Salmonella spp. and E. coli), yeasts and moulds. In the
stomach, the pH is decreased, reducing the concentration of all the types of
bacteria. In the small intestine, only the organic acids with antibacterial activity
are able to inhibit bacteria growth. This is the main reason that the use of these
acids has been proposed as a way of preventing or reducing the incidence of
diarrhoea in young pigs (Jensen et al., 2001; Tsiloyiannis et al., 2001; Piva et al.,
2002; Papatsiros et al., 2011). Thus, the organic acids are divided into two large
groups. In the first group are included those with indirect effect on the decrease
of the bacterial population by pH reduction and acting mainly on the stomach
because the animal organism has the  capability of preventing the decline in the
acidity in the small intestine by buffering the medium with bicarbonate (fumaric,
citric, malic and lactic acids).
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In the other group, are involved those organic acids (formic, acetic, propionic
and sorbic acid), that have the ability to reduce the pH and affect directly Gram-
bacteria by interfering in the bacterial cell with complex enzymes. The
antimicrobial effects of the organic acid ions, which act by controlling bacterial
populations in the upper gastrointestinal tract, are responsible for the beneficial
effects of these acids (Roth and Kirchgessner, 1998). Moreover, organic acids
can also enhance the effects of antibiotics by improving their absorption
(Radecki et al., 1988; Eidelsburger et al., 1992). In addition, acidifiers can have an
initial eradicating effect on bacteria in the feed (Lueck, 1980) and remain there as
a first barrier, preventing re-contamination.
 Mechanism of antimicrobial activity of organic acids
As undissociated organic acids are lipophilic, they can cross the cell membrane
of Gram negative bacteria, such as Salmonella. Once inside the cell, the higher
cytosolic pH causes the acid to dissociate, releasing hydrogen ions, which
consequently reduces the intracellular pH. Microbial metabolism is dependent on
enzyme activity, which is depressed at lower pH. To redress the balance, the cell
is forced to use energy to expel protons out across the membrane via the H-
ATPase pump to restore the cytoplasmic pH to normal. Over a period of
exposure expelling protons also leads to an accumulation of acid anions in the
cell (Lambert and Stratford, 1998), which inhibits intracellular metabolic
reactions, including the synthesis of macromolecules, and disrupts internal
membranes. Lactic acid bacteria are less sensitive to the pH differential across
the cell membrane, and thus remain unaffected. Inhibition of microbial growth
by this mode of action has been exploited for thousands of years in food
preservation; organic acids are natural by-products of microbial metabolism.
 The anion model of organic acid toxicity
Fermentative bacteria produce organic acids when oxygen is not available as
terminal electron acceptor, but they differ greatly in the types of acids that they
produce. Because the oxidation of one molecule must be coupled to the
reduction of another, anaerobic bacteria often produce several acids.
Fermentation acids are inhibitory when the pH is low but some bacteria are
much more resistant than others.
Traditionally, microbial growth inhibition by organic acids was explained by the
ability of these acids to pass across the cell membrane, dissociate in the more
alkaline interior and acidify the cell cytoplasm (Kashket, 1987).
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For many years it was assumed that bacteria maintained a slightly alkaline
intracellular pH, but this assumption was largely based on work with laboratory
cultures of E. coli (Padan et al., 1981).
It is now clear that many fermentative bacteria have the ability to let their
intracellular pH decline when the extracellular pH becomes highly acidic. This
decline in intracellular pH necessitates a metabolism that can tolerate a lower pH,
but the strategy appears to be highly adaptive. When intracellular pH remains
high, the pH gradient across the cell membrane can become very large. The
protons can be pumped back out of the cell, but the pH gradient causes a
logarithmic accumulation of the fermentation acid anions. By letting intracellular
pH decrease, the bacterium has a much smaller pH gradient across the cell
membrane and it is protected from anion accumulation.
Continuous culture studies with E. coli K-12 and O157: H7 indicated that the
two strains diferred greatly in their sensitivity to acetate at pH 5.9, and the ability
of O157: H7 to tolerate more acid than K-12 could be correlated with ability to
decrease intracellular pH (Diez-Gonzalez and Russell 1997). These experiments
also revealed another important observation about fermentation acid toxicity.
When the intracellular acetate concentration of K-12 increased there was a nearly
equal molar increase in intracellular potassium. These results indicated that
fermentation acid anion accumulation was at least in part an osmotic stress.
Recent work with Clostridium sporogenes, a silage and food contaminant, indicated
that it accumulated lactate anion at acidic pH values in accordance with the pH
gradient across the cell membrane, but lactate anion accumulation caused a
secondary effect (Flythe and Russell, 2007). When lactate anion increased, the
cells lost intracellular glutamate, and its fermentation scheme of amino acid
deamination is dependent on glutamate transaminase. The final result was a
virtually complete inhibition of ammonia production. The antimicrobial activity
of organic acids on other bacterial species has not been correlated with
intracellular pH regulation, but bacteria that could be classified as neutrophiles
seem to be more sensitive than those that are acid tolerant. For example, the
minimal inhibitory concentration (MIC) of acetic acid is 250 times lower for
Bacillus subtilis than lactobacilli (Hsiao and Siebert, 2002). The anion model of
organic acid toxicity explains why bacteria differ in their sensitivity to organic
acids, but it does not provide information on the antibacterial effect of one acid
versus another. The MIC for acetic, butyric, lactic and caprylic acid in E. coli are
less than 4 g/l, but this same bacterium is approximately 10-times more resistant
to malic, tartaric and citric acid (Hsiao and Siebert, 2002). This observation
indicates that factors such as chain length, side chain composition, pKa values,
and hydrophobicity could affect the antimicrobial activity.
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1.7.5 Formic acid
In animal nutrition the use of formic acid and its salts have been the subject of
investigation due to an antimicrobial action. Formic acid (also called methanoic
acid) is the simplest carboxylic acid and its mainly used as formate (the salt is less
corrosive and less toxic than the free acid). It can be found in plants and insects
where it mainly serves as defending agent. On the other hand, formate is an
integral part of the metabolism, especially in the transfer of 1-C intermediates
and in the synthesis of purines (Partanen and Mroz 1999).
Its chemical formula is HCOOH or HCOH. It is an important intermediate in
chemical synthesis and occurs naturally, most notably in the venom of bee and
ant stings. In fact, its name comes from the Latin word for ant, formica, referring
to its early isolation by the distillation of ant bodies. Esters, salts, and the anion
derived from formic acid are referred to as formates.
 Physical properties
Formic acid is a colorless liquid which freezes at 8.4° and boils at 101°. The
dielectric constant is 58. It has a sharp pungent odor and is miscible in all
proportions with water.
Formic acid tends to form azeotropes and a variety of these are known. Among
the more interesting are those containing tertiary ammonium formats which, as
shall be seen, have some interesting properties. Formic acid exhibits severe
toxicity as both an acute (short duration) local and acute systemic hazard. It
shows slight chronic (long duration) systemic toxicity and moderate chronic local
toxicity. Thus, exposure to skin, ingestion, and inhalation should be avoided
(Gibson, 1969).
 Chemical properties
 The aldehyde-like reducing properties of formic acid encouraged some early
chemists to postulate that formic acid is abnormal in structure More modern
techniques have shown this not to be the case, except that the ether C-O bond is
abnormally short, indicating much double bond character
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This undoubtedly contributes to its relatively high acidity. Formic acid is the
strongest of the unsubstituted alkanoic  monoacids. It has a pKa of 3.77 as
compared with 4.77 for acetic acid. Its relatively high acidity is due to the lack of
alkyl groups and their attendant electron release by an inductive effect.
This electron release causes destabilization of the carboxylate anions resulting
from ionization of the higher monocarboxylic acids (Gibson, 1969).
 Calcium formate and calcium diformate
Calcium formate (CaFO), Ca(HCOO), is the calcium salt of formic acid,
HCOOH. It is also known as food additive E238 in food industry. The mineral
form is very rare and called formicate. It is known from a few boron deposits. It
may be produced synthetically by reacting calcium oxide or calcium hydroxide
with formic acid (Lide et al., 1998).
Physically, calcium formate is an odourless, free-flowing white crystalline solid
and it is a convenient source of calcium and formate ions for aqueous  solutions.
Calcium formate actually has different uses in the industry: leather tanning (as a
masking agent in the chrome-tanning process), cement additive (CaFO imparts
a number of properties desirable in the final product, e.g. increased hardness and
decreased setting time in comparison to ordinary cements), gas generation (a
mixture of calcium formate with ammonium nitrate or with chlorate, perchlorate,
peroxide, superoxide or permanganate of an alkali metal evolves rapidally large
volumes of gas when ignited), flue-gas desulfurization, safety explosives
(calcium formate can be used as the fuel component in explosives designed to
have improved deflagration behaviour), de- icing agent (mixtures of calcium
formate with urea are excellent agents for the melting of ice), silage treatment
(calcium formate is commonly used as a component of an ensiling agent for
silage treatment).
The calcium formate in animal feed acts as a feedstock preservative and an
acidifying effect on the gastro-intestinal tract (Kil et al., 2011), and as a source of
calcium in cows and calves (Xu et al., 1998). The main difference between
calcium formate and calcium diformate, both used in animal feed
supplementation, is the percentage of inclusion of calcium and formic acid. The
calcium formate presents the 50 percent of calcium and the same percentage of
formic acid while the calcium diformate presents the 75 percent of calcium and
the 25 percent of formic acid.
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2 Objectives
The ban on the use of antibiotics as feed additives in animal nutrition has led to
a worldwide search and implementation of alternative strategies for preventing
the growth of pathogenic bacteria in farm animals, to maintain and improve the
health status and performance.
The objective of this thesis was to evaluate the effect both a species-specific
probiotic (Bacillus coagulans, Lactobacillus animalis and Lactobacillus paracasei spp.
paracasei) than an acidifier (calcium diformate) in calves. To achieve this objective,
three different trials were designed. In the first trial the effects of a species-
specific probiotic inclusion in 96 veal calves diet was investigate (Chapter 3), the
second one studied the effects of the same administered ptrobiotic on 22 dairy
calves (Chapter 4) and the last examined the effects of inclusion of calcium
diformate in the diet of 36 veal calves (Chapter 5). The studies evaluated the
effects of the administrations on health status, gut microbial balance and growth
performance. On veal calves the effects of probiotic and acidifier on slaughter
performance and histological survey were further evaluated.
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3. Specie-specific probiotic supplement in veal
calves diet: effects on zootechnical and
microbial parameters in standard rearing
conditions.
3.1 Abstract
The aim of the study was to evaluate the effects of the administration of a
species-specific probiotic supplement to veal calves on performance and
microbial parameters in standard rearing conditions. Ninety six male Friesian
veal calves (49.31 ± 1.38kg of body weight and 20±5 days of life) were divided at
random in two homogeneous groups of 48 animals each from the arrival in the
farm and fed either a basal diet (C) or a basal diet plus 1.8x109 CFU/head/day of
a probiotic supplement containing Bacillus coagulans, Lactobacillus animalis and
Lactobacillus paracasei spp. paracasei in a 35:30:35 ratio (T) for a total of 180 days.
Starting from 10th day from arrival and monthly until the end of the trial,
individual body weight (BW) was recorded and average daily gain (ADG) was
computed. At the same time, on the half of animals per group, faecal samples
were collected for faecal score (FS) evaluation, Lactobacilli count, Escherichia coli
count and Lactobacilli/E.coli ratio, while blood samples were collected for
haematological, haematochemical and immunological parameters evaluation.
During the whole experimental period daily health status and therapeutic
treatments were recorded for General Health Score (GHS) determination. At
slaughter 10 animals per group were analysed for macroscopically injuries
detection, and gut samples were collected for histological analyses. On each
subject carcass weight, dressing percentage, fattening condition, carcass grade
(SEUROP classification) and meat pH were recorded. During the trial were
considered six times (corresponding to the each month of fattening): from time
0, referred to the 10th day from arrival, to the last considered month (time 6).
BW resulted significantly higher (P≤0.05) in C calves than T at the 5th
(C=226.76kg vs T=223.27kg) and 6th (C=267.14kg vs T=263.56kg) considered
times while ADG was not different between groups. Faecal consistency was
significantly higher in T group at the 4th sampling (P≤0.01) as faecal Lactobacilli
content (C=8.37 Log10 vs T=8.49 Log10; P≤0.05). This trend could explain thebetter GHS observed in supplemented calves during the trial.
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At different times, some haematological parameters such as basophils,
aspartate amino transferase (AST), bilirubin, glucose, urea, bactericidal and
complement were higher (P<0.05) in C group, while non-esterificated fatty
acids (NEFA) and lactate dehydrogenase (LDH) showed lower values than T
(P<0.05). At slaughter no differences were observed for carcass weight,
dressing percentage, carcass grade and meat pH. The cecum histological
examination revealed a less evident de-epithelialisation and a greater integrity
of the epithelium surface in T subjects than C, while in both the ileum than in
cecum a numerical increase of the intestinal crypts’ depth was detected. The
administration of species-specific probiotic was able to improve the gut
microbiological balance and health status, with no evident effects on growth
performance.
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3.2 Introduction
Italy represents one of the largest Europe market for the veal calves trading. The
veal calf, among the livestock, is predisposed to stress syndromes caused by
breeding conditions and management: these subjects are immunologically
immature and the antibody levels are often extremely variable. This aspect tends
to be amplified by the breeding procedures in the farms: the calves are often
transported too early (not healed umbilical wound), and do not receive an
adequate colostrum administration in the early days of life, showing consequently a
marked sensitivity to conditioned diseases in the first weeks of life.
The different animals’ origin corresponding to a highly differentiated colostrum
immunitary profile, exacerbates the unfavourable environment conditions in
fattening farms.
The gastrointestinal and respiratory diseases most affect the veal calves:
diarrhoea is a major cause of mortality while respiratory problems cause
economic losses related to the use of treatments, and lower growth performance
(Timmerman et al., 2005).
In this context is necessary to reduce the use of antibiotics, given that the
microorganism’s resistance is currently considered one of the major public health
problems. Has been demonstrated that the resistant strains selection is able to
colonize the gut and consequently the environment. In particular, resistant
strains of Escherichia coli and Enterococci has been isolated from the veal calves’
intestinal content, in relation to the massive use of antimicrobial substances as
growth promoters in the past (Dir.97/72/CE; Busani et al., 2003).
To search new nutritional strategies allows to combine the economic needs of
farmer with the protection of consumers, the use of probiotics to improve the
performance of livestock is well know for a long time by now. These products
are used in the zootechnical practice to maintain the balance of the intestinal
microflora in order to ensure a better growth performance (Krehbiel et al., 2003)
and they are defined by Fuller (1989) as “a live microbial feed supplement, which
beneficially affects the host animal by improving its intestinal microbial balance”.
The probiotic action is expressed at various levels on intestinal microflora,
intestinal epithelial cells (Bontempo et al., 2006; Di Giancamillo, 2007) and the
immune-system (Sheridan et al., 1994). Especially for ruminants, the probiotic
dietary supplementation can improve microbial conditions in both the rumen
and the lower digestive tract (Elam et al., 2003) resulting in a better ability to
absorb nutrients (Giardini and Villa, 2007). The aim to be achieved with the
probiosis in calves is the maintenance of good digestive process of the calf,
which is reflected on a positive general health status.
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Currently probiotics in mixed culture are often used, but with low interest to the
species-specifity of the strains contained, with consequent loss of part of the
positive effect. The term “species-specificity” means the award of the probiotic
microorganism quality to a single clone and not to the species. In fact the
selection of lactic strains naturally resident in the digestive tract of veal calves,
allows enhancing the barrier effect against pathogenic bacteria thereby protecting
the intestinal mucosa from infection better than other non-species-specific
probiotics
The literature highlights the importance of the specificity strain for its probiotic
characteristics. To optimize the use of probiotic compounds in the farms the
identification of probiotic bacteria level clone species-specific isolated directly
from veal calves is crucial. It is also noted that is recognized a feature to a greater
formulated multi species/multi strain compared to administration of a single
species or a single strain (Timmerman et al., 2004).
The objective of this study was to evaluate within a made feedstuff, the
effectiveness of the probiotic species-specific selected in order to improve the
health conditions of calves by maintaining the bowel.
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3.3 Materials and Methods
The experimental trial was divided into two phases. The first was performed in
vitro and it allowed us to produce the probiotic formulation and its subsequent
technological, microbiological and stability checks.
During the second work phase an in vivo trial was carried out in order to evaluate
the efficacy of the probiotic on the health status and productive performances of
the veal calves in standard farming conditions.
3.3.1 Probiotic biomass production process and in vitro check of the product
The design and formulation of the probiotic compound was carried out at the
Department of Veterinary Sciences for Health, Animal Production and Food
Safety.
The three selected strains (Lactobacillus animalis DUP 5009, Lactobacillus paracasei
ssp.paracasei DUP 13077 and Bacillus coagulans RiboGroup 189-444) were
produced through fermentation in twin jet laboratory mixers.
Initially the strains were grown on nutrient agar, then inoculated into nutrient
broth, thus optimising the formulation of the growing means based on
fundamental growth and fisical parameters. The process of production of the
Bacillus coagulans was optimised for the formation of thermoresistant endospores.
The biomass development was measured by the means of the optical density and
of the dry weight of known volumes of centrifuged cultures followed by
lyophilisation.
The vital charge was measured by the means of life count on powder samples.
The obtained powders were kept at 4°C until the formulation of the probiotic
compound.
At the same time, microbiological analyses were carried out (method IDF STD
50B:1985) using serial dilutions 1:10 and triple analyses to evaluate the stability
of the produced strains (Marossi et al., 1999), in order to test the product
stability at room temperature, at 42°C and at refrigeration temperature. The
stability of the formulation was also tested in seasonal stress conditions (i.e.,
freezing/defrosting and 37°C-refrigeration).
The control of the quantity of every microorganism in the mixture was obtained
thanks to a morphological evaluation of the the strain colonies. To evaluate the
cloning conservation of the strains, ribotyping was performed on liophylised
elements.
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The evaluation of the contaminant microorganisms was carried out both on the
liophylised elements in pool, and on each individual liophylised strain by the
means of liquid culture, to the exception of those used for the count of
coagulase-positive staphylococci analysed through streaking.
Determination Coliform bacteria ISO 4832:1991 with growth medium: Violet
Red Bile Agar; determination of E.coli Method as per Afnor- Bio 12/5-01/99
with growth medium: Coli ID; determination coagulase-positive staphylococci
ISO 6888-1:1999 growth medium used: Baird Parker Agar. Finally, for the
coagulase test a commercial test was used. The method used for yeasts and
molds was ISO 7954:87 and the used growth medium was Sabouraud Dextrose
Agar w/cloramphenicol. In order to evaluate the overall Mesophile bacteria
count the method ISO 4833:91 was applied on Gelisato Agar growth medium;
whilst for the determination of Salmonella spp the method ISO 6579:2002 was
applied.  The composition of the formulation used for this experimental test was
the following: 30% of Lactobacillus animalis DUP 5009; 35% Lactobacillus paracasei
spp. paracasei DUP 13077; 35% Bacillus coagulans RiboGroup 189-444.
In order to better understand the microbical activity of the strains, the inhibition
test on dish was carried out. The strains used for the test were the following:
Escherichia coli ATCC 25988, Listeria monocytogenes ATCC 19115, Salmonella
tiphymurium ATCC 14028.
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3.3.2 Animals and Experimental Design
Ninety-six veal calves of Friesian Breed, 94 males and 2 females (20±5 days of
life, 49.31±1.38 kg of body weight) were randomly divided into 2 experimental
groups composed of 48 animals each.
Control group (C) received a basal diet (consisting in milk replacer plus
concentrate), while treated group (T) received the same basal diet as C but
supplemtented with the species-specific probiotic compound (109
UFC/animal/day). Both experimental diets were isoproteic and isoenegetic
following Nutrient Research Councill (NRC, 2000) reccommendations for veal
calves for each phase of the rearing system, the probiotic dosage was doubled in
case of a individual antibiotic treatment.
The calves were located in the same building at the same environmental
conditions, not artificially conditioned and in collective boxes of 6 calves each
equipped with a concrete slatted floor. The experimental planning of the in vivo
phase was divided into two periods: the first lasted for 10 days and it allowed the
animals to get used to the management conditions and procedures (adaptation
period): during this period the same C basal diet used was administered both to
control and trated animals. The second, period lasted for 180 days and consisted
of dietary supplementation of the species-specific probiotic compound to T
animals. The milk replacer (Tab.1) was administered to all the experimental
animals twice a day, at 7:00AM and 5:00PM; while the concentrated (Tab.2) was
given at 12:00AM starting from their 31st day of life.
From the  beginning of the trial until the end of the experimental period, calves
were feed increasing amounts of milk ranging from 2 litres/meal to
9.5litres/meal. During the trial three different milk powders were used from a
startet type, during the first 80 days, to a growing-finishing type until slaughter.
The passage from starter milk replacer to growing-finishing milk replacer was
obtained mixing the two milk powder in increasing concentration for the last
one.
The inclusion of milk powder was 100g/L during the first 100 days of the trial,
while a mean concentration of  135 g/L was adopted during the last three
months. Reconsitution temperature of milk was 72°C, while service temperature
was 37°C. The amount of administered concentrated feed* composed by 50% of
corn grain and 50% of corn silage, (starting from the 31st day of test) was initially
equal to 200gr/calf/day and it was increased up to 700gr/day at the end of the
trial.
* Milk powder and concentrate were provided by Zoogamma s.p.a. (VanDrie Group. Borgo Satollo,
Ghedi, Brescia)
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Table 1: Administered milk replacer: chemical anlyses of the three different administered type
Table 2: Administered concentrate: chemical analyse
Chemical Analyses
(% a.f.)
Start FE
(% a.f.)
Elite 20
(% a.f.)
Elite 100
(% a.f.)
Humidity 5.00 5.00 5.00
Raw protein 22.00 19.00 20.00
Raw fibre 0.50 0.30 ---
Fat 18.00 17.00 18.50
Ash 8.00 7.80 7.80
Vit.A (IU) 25,000.00 25,000.00 25,000.00
Vit. D3 3,000.00 3,000.00 3,000.00
Vit. E (mg) 150.00 50.00 50.00
Vit. C (mg) 150.00 40.00 40.00
Fe  (mg) 50.00 --- ---
Cu (mg) 10.00 5.00 5.00
Chemical Analyse
Dry Matter
(%)
As Fed
(%)
Humidity 42.31 ---
Raw protein 19.96 7.62
Raw fibre 4.25 2.50
Fat 4.41 2.59
Ash 4.25 2.50
Starch 76.32 44.87
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3.3.3 Growth performance
The individual BW of each calf was recorded montly during the trial, starting
from the 10th day from the arrival in the farm by an electronic precision scale
(100 grams sensitivity). According to recorded BW, the ADG was subsequently
calculated.
3.3.4 Faecal parameters and microbiological status
In order to highlight calves with enteritis problems (diarrhoea) and evaluate the
livestock nutritional management, extimated FS was recorded monthly for the
evaluation of the macroscopic status of the faeces of each calf. Each animal was
given a mark from 1 to 5 (1: very hard faeces; 5: very liquid faeces). Moreover
individual faecal samples were taken monthly on a half of the calves by rectal
stimulation. Faecal sample were subsequently pooled (three animals of the same
box per pool), stored in vials with transport medium (Faecal TM enteric Plus,
Oxoid, Basingstoke, UK) at 4°C, and immediately delivered to laboratories.
Pooled faecal samples were than analysed within 24 hours using the official
methods IDF STD 50B:1985 on growth medium MRS (DeMan Rogosa Sharp
Agar) for the identification of Lactobacilli; whilst in order to identify E.coli the
AFNOR-Bio 12/5-01/99 method on growth medium Coli ID was used. The
serial dilutions applied to both determinations were equal to 1:10.
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3.3.5 Health Status
During all the trial period the health status of the calves was constantly
monitored and all antibiotic treatments performed were recorded, on both
individual and collective basis.
Incidence of diarrhoea and therapeutic tratments lead to the calculation of the
General Health Score (GHS) index for each calf as reported by Timmerman et al.
(2005) with the following formula:
15 – (1 X n. total days with diarrhoea) – (2 X n. of individual therapeutic
treatments for digestive system pathologies) – (3 X n. of individual therapeutic
treatments for breathing system pathologies) – (2 X n. of mass therapeutic
treatments).
Animals affected by pathologies episodes were isolated from the other animals
and lodged in a specific dedicated area. Incidence of pathology and mortality rate
were recoded during all the experimental trial.
3.3.6 Haematological parameters
Starting from the 10th day from the arrival and monthly, blood samples were
collected on half of the tested animals for each experimental group. Samples
were taken from the jugular vein by the means of a 10ml vacuum test tube
(Terumo Venosafe 10 ml VF-109SHL, Terumo Europe L.V., Leuven, Belgium).
The refrigerated samples were subsequently delivered at the laboratory
determinations.
The considered haematological, hematochemical and ossidative stress parameters
were as follow: red blood cell count (RBC), haemoglobin (HB), hematocrit (HT),
mean cell volume (MCV), mean cell haemoglobin (MCH), mean cell
haemoglobin concentration (MCHC), platelets (PLT), white blood cells (WBC)
and leukocyte formula, total proteins, albumin, alfa-, beta-, gamma-globulins,
albumins/globulins ratio, not-esterified fatty acids (NEFA), aspartate
aminotransferase (AST), gamma glutamyl transferase (GGT), total bilirubin,
creatin kinase (CK), glucose, creatinine, urea, anti-oxidant power (OXID) and
reactive oxygen metabolites (ROM’s).
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3.3.7 Slaughter Parameters
Upon slaughtering (180th test day), 10 calves per group were necroscopically
analysed to determine the presence of macroscopic lesions. Immediately after
slaughtering, the whole gastrointestinal tract was isolated and a 1cm3 sample of
its surface was taken from the small intestine and the cecum. All the samples taken
were stored in paraformaldehyde in PBS at 4%. They were subsequently tested
for: histological profile of the small and cecum intestine, structural aspect of the
intestinal mucous membrane, evaluation of the height of the intestinal villi and
crypts and their relationship (V:C ratio), immunohistochemical parameters (small
and cecum intestine: anti-PCNA and TUNEL method),
immunohistochemical/histometric (small and cecum intestine: count of the
epithelial cells with PCNA-positive nucleus and TUNEL-reactive) and
immunohistochemical parameters (small and cecum intestine: anti IgA).
Moreover for each analysed calf any eventual macroscopic lung lesions were
evaluated (Redaelli et al., 2006). Also any inflammations of the lung parenchyma,
of the bronchial tube and of the pleural membrane were taken into consideration.
A sample of the lung parenchyma was taken from each of the selected subjects
in order to perofrm an histological evaluation of lesions of the lung tissue, giving
a mark from 0 to 5 according to the growing seriousness of the lesions.
The carcass dressing percentage was evaluated for each of the slaughtered calves.
The same carcasses were classified according to the SEUROP category
assignment as per the EC regulations 1208/81 and 1026/91 (S=superior; E=
excellent; U=very good; R=good; O=rather good; P=mediocre).
At the same time the meat pH was evaluated 45 minutes and 24 hours after
death.
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3.4 Statistical Analysis
Live BW, ADG, FS, GHS, blood parameters, and meat pH were analysed by a
MANOVA procedure for repeated measures of SAS/STAT, (Version V8, 1999,
SAS Inst, Inc., NC, U.S.A.) including the fixed effect of the treatment, day, and
the interaction treatment x day and considering the box or the animal as the
experimental unit.
Lactobacilli count, Escherichia coli count, Lactobacilli/E.coli ratio and slaughtered
data were analysed by a General Linear Model (GLM) procedure of (SAS/STAT,
Version V8, 1999, SAS Inst, Inc., NC, U.S.A.) including the fixed effect of the
treatment and considering the group as the experimental unit. The significance
was declared at P≤0.05.
Histometric data (villus height, crypt depth, V:C ratio) were analysed by
ANOVA using the mixed procedure of the SAS package (Version V8, 1999, SAS
Inst, Inc., NC, U.S.A.). The model included treatment as fixed effect and the calf
as random effect. The data were presented as least squared means ± SE.
Differences between least squared means were analysed by orthogonal contrast
and considered significant at P ≤0.05.
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3.5 Results
3.5.1 Growth performance
In  the present trial, dicreased BW was found in T animals than C on months 5
and 6 (Tab.3), (respectively -3,49kg and -3,58kg), while no differences in ADG
between the groups were foundd (table 4).
Table 3: Body weight (BW) registered during the trial in in veal calves (a,b=P≤0.05)
Table 4: Average daily gain (ADG) evaluated during the trial in in veal calves
TIME GROUP P
(Month) C T SEM GROUP TIME G*T
BW Initial 50.02 48.59 1.38 ≤0.01 ≤0.01 0.96
(kg/h) 1 71.11 68.89
2 99.51 98.11
3 145.80 143.29
4 181.22 179.68
5 226.76a 223.27b
6 267.14a 263.56b
TIME GROUP P
(Month) C T SEM GROUP TIME G*T
ADG 0-1 0.73 0.70 0.07 0.30 ≤0.01 0.65
(kg/h/d) 1-2 0.98 1.00
2-3 1.36 1.36
3-4 1.42 1.58
4-5 1.34 1.30
5-6 1.44 1.39
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3.5.2 Microbiological and faecal
Faecal score was significantly improved in T group on the 4th month of the trial
(Tab.5).
TIME GROUP P
ITEM (Month) C T SEM GROUP TIME G*T
Faecal Score Initial 1.25 1.60 0.16 0.09 0.61 0.08
1 1.56 1.27
2 1.56 1.58
3 1.51 1.27
4 1.86A 1.27B
5 1.53 1.44
6 1.45 1.31
Table 5:Macroscopical evaluation of the feces (Faecal score) during the trial in veal calves
(A,B=P≤0.01)
No differences were detected between the two experimental groups for
Lactobacilli faecal content except for increased values in T animals in the 4th
month of the trial (P<0.05).
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Table 6: Lactobacilli count in feces of veal calves during the trial (a,b=P≤0.05)
In the same way both E.coli (tab.7) and Lactobacilli/E.coli ratio (tab. 8) were not
influenced by species-spoecific probiotic compound.
Table 7: Escherichia coli (E.coli) count in feces of veal calves during the trial
TIME GROUP
ITEM (Month) C T SEM
Lactobacilli (Log10) 1 8.12 7.81 0.17
2 8.45 8.43 0.17
3 8.39 8.62 0.19
4 8.37b 8.49a 0.17
5 8.35 8.88 0.17
6 8.49 8.63 0.17
Average 8.36 8.48 0.07
TIME GROUP
ITEM (Month) C T SEM
E.coli (Log10) 1 4.16 3.91 0.27
2 6.66 6.60 0.26
3 6.86 6.81 0.26
4 6.86 6.95 0.25
5 6.86 6.88 0.25
6 6.79 7.01 0.25
Average 6.36 6.36 0.25
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Table 8: Lactobacilli/E.coli ratio in feces of veal calves during the trial
3.5.3 Health status
The GHS did not show any significant difference between the two experimental
groups (Tab.9); however, it must be outlined a tendence to increased values in T
group than C starting from time 2 that couple with the higher isolation rate for
severe pathologies (4,17% T vs 16,67% C) and number of deaths in C calves
(mortality equal to 8.33% vs 2.08% of group T).
TIME GROUP P
ITEM (Month) C T SEM GROUP TIME G*T
GHS 1 9.35 8.89
2 11.58 11.87
3 10.67 11.48
4 12.48 13.91
5 11.81 12.83
6 8.96 10.64
Table 9: General health status evaluation (GHS) in veal calves during the trial
TIME GROUP
ITEM (Month) C T SEM
Lactob./E.coli ratio (Log10) 1 4.03 3.95 0.31
2 1.74 1.83 0.31
3 1.52 1.80 0.33
4 1.51 1.55 0.30
5 1.49 2.00 0.30
6 1.70 1.68 0.31
Average 2.00 2.13 0.12
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3.5.4 Haematological parameters
The haematological, hematochemical, immunological paramenters were similar
in the two groups for most of the sampling times (Tab.10 a,b; Tab 11a,b).
Significant initial (time 0) lower average corpuscular volume (MCV) values were
detected in group T (C = 35 fl vs T = 33 fl; P≤0.01), while lower content of
basophiles was detected in T calves at time 2 (C = 1.3% vs T = 0.8%; p<0.05).
Despite the little dietary Fe intake, the haemoglobin values were within the
superior limit fixed by the law (7.3 g/dl) for all test period in both experimental
groups.
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TIME GROUP P
ITEM (Month) C T SEM GROUP TIME G*T
RBC Initial 8.46 8.64 0.20 0.29 <0.01 0.85
(M/µl) 1 9.11 9.22
2 9.80 9.55
3 9.40 9.16
4 8.75 8.55
5 8.68 8.43
6 8.10 7.81
HCT Initial 29.77 28.54 0.05 <0.01 <0.01 <0.01
(%) 1 27.66 26.77
2 29.08a 26.04b
3 25.06 23.73
4 24.84 23.54
5 23.36 21.78
6 23.36 21.78
HGB Initial 9.35 8.86 0.25 0.02 <0.01 0.86
(g/dl) 1 8.97 8.74
2 9.45 9.52
3 9.33 8.99
4 8.48 7.91
5 8.46 8.04
6 7.97 7.42
MCV Initial 35.13A 33.14B 0.50 <0.01 <0.01 <0.01
(fl) 1 30.36 29.14
2 30.00 29.04
3 29.68 28.78
4 28.58 27.98
5 28.89 28.02
6 28.89 27.98
MCH Initial 11.05b 14.59a 0.09 0.91 0.04 0.51
(pg) 1 9.82 9.34
2 10.20 9.79
3 10.02 9.62
4 9.58 9.04
5 9.82 9.27
6 9.83 1.27
Table 10a: Haematological parameters in veal calves during the trial (A,B=P≤0.01; a,b=P≤0.05)
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TIME GROUP P
ITEM (Month) C T SEM GROUP TIME G*T
MCHC Initial 31.46 31.01 0.22 0.91 <0.01 0.39
(g/dl) 1 32.38 32.63
2 33.91 34.38
3 34.26 34.21
4 33.64 33.32
5 34.00 34.20
6 34.05 34.06
RDW Initial 29.53 28.73 4.21 0.98 0.69 0.32
(%) 1 35.50 26.25
2 27.76 27.51
3 27.27 25.58
4 26.71 26.21
5 25.37b 37.41a
6 24.97 25.89
PLT Initial 1191.87 1268.47 60.28 0.01 <0.01 0.97
(K/µl) 1 697.97 838.62
2 790.15 888.29
3 700.54 748.78
4 817.02 851.51
5 703.66 811.43
6 627.96 752.68
Table 10b: Haematological parameters in veal calves during the trial (a,b=P≤0.05)
80
TIME GROUP P
ITEM (Month) C T SEM GROUP TIME G*T
WBC Initial 7.48a 6.32b 0.35 0.35 <0.01 0.58
(K/µl) 1 6.95 6.63
2 7.01 6.82
3 7.75 7.67
4 7.76 7.93
5 7.36 7.37
6 7.03 7.16
Neutrophils Initial 30.97 29.35 2.30 0.40 <0.01 0.36
(%) 1 40.54 44.99
2 32.43 34.72
3 29.46 27.51
4 32.03 28.68
5 38.05 33.03
6 31.46 28.24
Limphocytes Initial 58.24 58.07 2.40 0.56 <0.01 0.32
(%) 1 42.76 37.5
2 52.32 50.27
3 57.60 58.33
4 57.34 60.62
5 48.74 53.55
6 55.47 60.32
Monocytes Initial 10.32 11.86 0.65 0.49 <0.01 0.45
(%) 1 15.56 15.9
2 13.96 13.6
3 11.43 12.8
4 9.62 9.86
5 12.13 12.02
6 11.06 10.06
Table 11a: Leukocyte formula in veal calves during the trial (a,b=P≤0.05)
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TIME GROUP P
ITEM (Month) C T SEM G T G*T
Eosinophils Initial 0.14 0.14 0.23 0.89 <0.01 0.75
(%) 1 0.22 0.47
2 0.37 0.57
3 0.71 0.56
4 0.18 0.04
5 0.48 0.65
6 1.44 0.97
Basophils Initial 0.29 0.55 0.13 0.89 <0.01 0.05
(%) 1 0.92 1.14
2 1.33A 0.77B
3 0.77 0.74
4 0.81 0.81
5 0.57 0.76
6 0.53 0.39
Table 11b: Leukocyte formula in veal calves during the trial (A,B=P≤0.01)
Hepatic, renal and muscle-skeletal functionalities related parameters did not
show differences between the test groups (Tab.12a-d) in most of the cases.
Some few differences were detected at different times for AST (T6: C=3.4 UI/L
vs T=3.0 UI/L; P<0.05), bilirubin (T2: C=3.6µmol/L vs T=2.83.6µmol/L;
P<0.05), glucose (T6, C=61g/L vs T= 58,5 g/L; P<0.05), NEFA (T3: C=0,3
mmol/L vs T=0.4mmol/L; P<0.05), urea (T0: C=3.9mmol/L vs T=3.4mmol/L;
P<0.05; T1: C=1.6mmol/L vs T=1.1mmol/L; P<0,05), and LDH (T3:
C=127UI/L vs T=236UI/L; P<0,05). Immunological parameters were not
influenced by the dietary administration of the species-specific probiotic
compound except for  lower values for the bactericidal activity  (T1: C = 77,5 %
vs T = 47,1 %; P<0.05), for the complement (T1: C = 27,3 UEC H50/150µl vs T
= 18,8 UEC H50/150µl; P<0.05), and the lysozyme (at time T0, T1, T3 and T6)
in T than C.
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TIME GROUP P
ITEM (Month) C T SEM GROUP TIME G*T
AST Initial 60.96 58.67 3.16 0.06 <0.01 0.11
(IU/L) 1 56.13 52.82
2 66.35 60.24
3 70.38 64.33
4 75.59 83.81
5 65.24 61.2
6 113.55 102.34
Bilirubin Initial 4.18 4.19 0.22 0.07 <0.01 0.28
(µMol/L) 1 3.63 2.83
2 4.32A 4.18B
3 4.47 4.11
4 4.83 4.53
5 3.19 2.98
6 4.19 4.40
Glucose Initial 6.00 5.72 0.20 0.07 <0.01 0.04
(Mmol/L) 1 6.52 6.58
2 5.35 6.02
3 6.52 6.93
4 6.50 6.44
5 5.30 5.22
6 6.17 7.11
Tot.Protein Initial 61.08 58.53 0.80 0.08 <0.01 0.60
(g/L) 1 59.51 58.58
2 58.25 58.04
3 61.56 62.14
4 66.68 66.15
5 58.81 57.55
6 68.09 66.88
NEFA Initial 0.20 0.21 0.24 0.10 <0.01 0.49
(Mmol/L) 1 0.23 0.24
2 0.27 0.27
3 0.34 0.42
4 0.28 0.30
5 0.38 0.39
6 0.24 0.25
Tab 12a: Biochemical and immunological parameters in veal calves during the trial (A,B=P≤0.01)
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TIME GROUP P
ITEM (Month) C T SEM GROUP TIME G*T
Creatinine Initial 110.44 107.09 2.41 0.91 <0.01 0.71
(µMol/L) 1 66.16 62.54
2 52.29 52.08
3 63.36 63.97
4 71.49 74.14
5 59.39 60.76
6 63.45 65.01
Urea Initial 3.85 3.44 0.12 <0.01 <0.01 0.79
(Mmol/L) 1 1.57 1.09
2 1.89 1.58
3 1.73 1.59
4 2.67 2.44
5 2.33 2.06
6 2.86 2.54
GGT Initial 48.50a 38.21b 1.30 0.65 <0.01 0.72
(IU/L) 1 25.00 23.17
2 22.04 19.50
3 22.14 19.57
4 24.67 22.87
5 22.00 20.59
6 29.60 27.70
CK Initial 218.79 189.33 60.32 0.21 <0.01 0.61
(IU/L) 1 113.35 99.38
2 153.78 131.88
3 126.77 119.00
4 174.00 199.17
5 85.76 82.18
6 252.30 270.39
LDH Initial 2069.29 1906.63 9.81 <0.01 <0.01 0.40
(IU/L) 1 2101.26 2051.04
2 2479.48 2311.08
3 2663.77 2367.09
4 2688.22 2806.00
5 2507.57 2431.50
6 3538.40 3311.00
Tab 12b: Biochemical and immunological parameters in veal calves during the trial (a,b=P≤0.05)
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TIME GROUP P
ITEM (Month) C T SEM GROUP TIME G*T
Lisozyme Initial 1.03 1.41 0.08 <0.01 0.04 0.82
(µg/ml) 1 0.96 1.39
3 1.07 1.39
6 1.16 1.63
Battericidal Initial 93.57 87.72 3.55 <0.01 <0.01 <0.01
(%) 1 77.55 47.14
3 91.48 89.96
6 83.14 83.68
Haptoglobin Initial 0.03 0.01 0.02 0.88 0.16 0.32
(Mg/ml) 1 0.01 0.007
3 0.03 0.048
6 0.048 0.05
Complement Initial 13.94 15.28 1.20 0.10 <0.01 <0.01
(UEC H50/150 1 27.3 18.82
µMol) 3 18.92 19.28
6 17.2 18.26
Albumin G Initial 27.18 27.48 5.19 0.91 0.12 1.00
(g/L) 1 24.52 25.79
3 36.35 36.61
6 27.42 28.11
Tab 12c: Biochemical and immunological parameters in veal calves during the trial
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TIME GROUP P
ITEM (Month) C T SEM GROUP TIME G*T
Alpha Globuline Initial 9.92 9.20 2.20 0.91 0.31 1.00
(g/L) 1 8.40 8.67
3 12.30 12.02
6 12.58 10.60
Beta Globuline Initial 7.12 7.17 0.25 0.58 <0.01 0.47
(g/L) 1 6.59 6.90
3 7.67 8.14
6 10.93 10.7
Gamma Globuline Initial 6.57 6.82 1.60 0.65 <0.01 0.51
(g/L) 1 7.52 8.72
3 12.52 9.41
6 13.53 13.28
Alfa/Gamma Initial 1.18 1.21 0.03 0.92 <0.01 0.45
Globuline 1 1.11 1.07
3 1.07 1.07
6 0.79 0.83
Tab 12d: Biochemical and immunological parameters in veal calves during the trial
The oxidative stress parameters did not show any significsnt differences between
the experimental groups, highliting however the presence of an adaptative stress
in the calves with high levels of OXID at time 0 (C=513 µmol HClO/ml vs
T=475 µmol HClO/ml; P<0.05) (Tab.13).
TIME GROUP P
ITEM (Month) C T SEM GROUP TIME G*T
OXID Initial 513.57 475.03 7.44 0.03 <0.01 <0.01
(µMolHClO/m) 1 261.73 258.28
6 189.42 191.11
ROMS Initial 4.41 4.26 0.24 0.60 <0.01 0.82
(Mmol H2O2) 1 1.19 1.25
6 2.03 1.83
Tab 13: Evaluated oxidising stress parameters in veal calves during the trial
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3.5.5 Slaugher parameters
Slaughtering performance did not show any significant differences for carcass
weight and dressing percentagfe between the groups (Tab.14).
Table 14: Carcass weight and dressing percentage of veal calves fed a species-specific probiotic
Both pH at 45 minutes and 24 hours after slaughter, did not show any
differences between the groups (Tab.15).
Table 15: Carcass pH at zero, 45 minutes and 24 hours after slaughter in veal calves fed a species-
specific probiotic compound
GROUP
ITEM C T SEM P
Carcass Weight (Kg) 148.77 146.61 2.17 0.50
Dressing Percentage (Kg) 55.75 55.69 0.51 0.94
GROUP P
ITEM TIME C T SEM GROUP TIME G*T
pH (mixed) Initial 6.22 6.24 0.04 0.59 ≤0.01 0.387
45’ * 6.70 6.68
24h* 5.73 5.80
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The SEUROP classification of carcasses revealed both increased type R and
Type P frequence of carcasses in T group, while C animals had type O carcasses
in most of the cases. (Tab.17).
Table 17: SEUROP classification of veal calves carcass
3.5.6 Histological and histometrical parameters
Considering the histological and histometrical evaluation of intestinal samples of
calves upon slaughtering, it did not show any difference between the groups;
however, the possible protective effect of the probiotic compound tested was
confirmed by the presence of less serious histopathologies in cecum for T group,
with a greater integrity of the superficial epithelium.
The administration of the species-specific probiotic compound in the calves diet
was able to determine a numerical increase of the depth of the crypts in the
ileum and the caecum intestine, while dicreasing the number of cells in
replication at the level of ileum and cecum crypts (Fig.1-2). Obtained results on
histological examination also showed a tendency to a reduction in the number of
cells in replication, apoptotic activity in the ileum lymphatic tissue, and Ig-A
positive immunocompetent cells in the GALT (gut-associated lymphoid tissue)
of treated calves (Fig. 3-6).
EUROPE CLASSIFICATION CONTROL TREATED
S 0 0
E 0 0
U 0 0
R 0 4.26% (2 subjects)
O 97.5% (39 subjects) 91.49% (43 subjects)
P 2.5% (1 subject) 4.26% (2 subjects)
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Figures 1 and 2: Microanatomical aspects of ileum (Fig.1, C group, 40X) and cecum (Fig. 2, T
group, EE 200X). A chronic catarrhal enteritis with a severe de-epithelialisation and a loss of
superficial epithelium can be observed in the ileum. Cecum microanatomical aspects do not
evidence epithelial injuries in T subjects.
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Figures 3 and 4: Microanatomical aspects of ileum (Fig.3, group C, anti-PCNA 100X; Fig.4,
group T, anti-PCNA 200X). Immunoreactive to anti-PCNA are observed both in epithelial
cells of the intestinal crypts and in immunocompetent cells of the TLD and the GALT (mainly
lymphocytes).
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Figures 5 and Figures 6: Microanatomical aspects of ileum (Fig.5, T group, TUNEL 100X; Fig.6, C
group, TUNEL 200X). Apoptosis in the TLD and the GALT (mainly macrophages) in both groups of
animals are evident.
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3.5.7 Lungs evaluation at the slaughter
The evaluation of lungs upon slaughtering showed chronic pleural lesions in
most of the calves (adherences) and lesions of the pulmonary parenchyma. The
observed lesions could be attributed to subacute-chronical inflammatory forms,
generally quite common in veals calves. Histological samples analysis confirmed
the presence of subacute-chronical bronchial pneumonia (Fig. 7 and 8) and
interstitial pneumonia.
Figures 8 and 9: Different extensions of bronchial pneumonia in lungs of veal calves
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3.6 Discussion
The concern on massive use of antibiotics in animal production impose the use
of alternative substances that may be effective on both animals’ health and
consumer’s health. Among different compounds, probiotics seem to be able to
influence performance goes throught the henhancing of the positive intestinal
microflora (Lalles et al., 2007; Corcionivoschi et al., 2010; Frizzo et al., 2011), the
reduncing of diarrhoea incidence (Timmerman et al., 2005; Mokhber et al., 2007;
Nagashima et al., 2010; Frizzo et al., 2010; Kawakami et al., 2010), and the
improving both the innate and acquired immunity (Fleige et al., 2008; Frizzo et al.
2010; Al-Saiady et al., 2010).
Anyway a number of studies have been carried out in order to determine the
effects of probiotic dietary supllementation on growth performance, but the
obtained results have so far been discordant. In some cases the probiotics given
to veal calves not always allowed to highlight increased body weight or dressing
percentage at slaughtering (Bakhshi et al., 2006; Riddell et al., 2010) altought
some authors found positive results (Frizzo et al., 2010; Kawakami et al., 2010;
Nagashima et al., 2010; Al. Saiady et al., 2010; Hossaini et al., 2010).
Such inconsistencies are not easily interpreted: the sensibility to the probiotic is
dependent to different factors (Timemrman et al., 2005) as the type, the strain
and species-specificity of the administered compound (Ohashi et al., 2006;
Ripamonti et al., 2011) where the most species-specific the probiotic is, the most
effective should be (Vinderola et al., 2004).
Whether it is true that the action of probiotics is obtained by the improvment of
the intestinal dismicrobism and, as a consequence, of the overall health status,
there are however many factors (intrinsic and extrinsic) that can influence the
calf’s status. In addition to this, in not particularly stressful managerial conditions,
the effects of the administration of such compunds could be hidden.
In the present study ADG did not show any difference between the two
experimental groups confirming previous studies (Bakhshi et al., 2006; Riddell et
al., 2010). The lack of increased preformance can be partially explained also by
the use of antibiotics during the trial that can have influenced the mechanism of
action of the probiotics compound.
To confirm this hypothesis, starting from the last mass antibiotic administration
(3rd test time), a better faecal consistency was observed (significant at 4th time) in
T group: this could indicate a better stability of the intestinal microbial
conditions. Such tendency was confirmed by the faecal count of lactobacilli and,
even if not significant, by an increased Lattobacilli/E.coli ratio in the group
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supplemented with the species-specific probiotic compound in agreement with
Signorini et al. (2010).
Moreover a better intestinal microbiological balance in calves fed probiotic can
be observed by the improvement of an indirect health indicator such as GHS or
by the lower incidence of mortality rate observed
The blood determinations did not show relevant differences between the two
experimental groups, confirming what stated by some authors previously (Riddel
et al., 2010; Adams et al., 2010; Al-Saiady et al., 2010). In the present study there
was no haemoglobin and hematocrit increase in agreement with Kim et al.
(2011), and the protidemy trend was characterised by an initial reduction of the
antibody quantity of colostral origin, followed by an antibody title increase as
reported by Kim et al. (2011).
Differently from Fleige et al. (2007), in the present study no positive
immunemodulatory effect in collected blood samples was observed in calves fed
the species-specific probiotic compound. Considering that such parameters may
be influenced by stressogen factors, it is possible to hypothesize that both the
use of antibiotics during the trial, and the lack of high environmental stress
factors can have masked the expected positive effects.
The intestine not colonised by pathogenic germs is capable of absorbing some
substances and amminoacids more efficiently (Elam et al., 2003). If a thinner
lamina propria results in more efficient nutrient absorption, then ADG and feed
efficiency should be improved.
In the present study the obtained results of the immunohistochemical and
istometrical considered parameters agree with the hypothesis that species-
specific probiotics dietary administration may be indirectly linked to a protecive
action of the intestinal mucous membrane, with the preservation of the barrier
integrity, expecially in the cecum (Connolly et al., 2008).
The lower incidence of serious cecum histopathological lesions evidenced during
the trial in probiotic-fed calves with a less evident disepithelization confirm
findings by previous authors (Waters et al., 1999; Casas et al., 2000; Blatter et al.,
2001) who found positive results over the intestinal ephitelium integrity in
animals fed probiotics.
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3.7 Conclusions
The present study showed how species-specific probiotic compound dietary
administration to veal calves can positively affects the intestinal mucosal integrity
and the microbial population of the gastro intestinal tract with some positive
results over health status of treated animals, although a strong negative effect of
antibiotic treatments can be outlined over effectiveness of treatment.
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4 Species-specific probiotic in newborn female
calves: microbiological and general health
status, growth performance, haematological
parameters and cell mediate immune response.
4.1 Abstract
This study evaluated the effects of the administration of a species-specific
multistrain probiotic (Lactobacillus animalis-Lactobacillus paracasei subsp. paracasei-
Bacillus coagulans; 30:35:35) on health and performance parameters of newborn
Friesian female calves during the first month of life.
Twenty-two calves were divided in two groups: control (C) fed with milk
replacer and concentrate as a basal diet, and treatment (T), fed C diet plus
1g/head/d of probiotic from the second day after birth to the end of the first
month of life. Faecal samples were collected weekly for the count of Lactobacilli
and Escherichia coli; blood samples were collected and analyzed weekly. Individual
faecal score (FS) was recorded daily, General Health Score (GHS) was calculated
at the end of the trial, and cell mediate immune response was evaluated by skin
test at 7 and 28 days of life. Body weight (BW), biometrical parameters and
Average Daily Gain (ADG) were recorded weekly while Feed Intake (FI) and
Feed Conversion Rate (FCR) were recorded for the overall period. Higher faecal
Lactobacilli/E. coli ratio on day 28 of life (3.73 Log UFC/g vs. 2.02 Log UFC/g;
P<0.05) and improved faecal consistency at 6, 25 and 27d of life were found in
T group. Final body weight (48.92 Kg vs 46.92 Kg; P<0.05) and hearth girth
(81.16 cm vs 78.49 cm; P<0.05) were significantly higher in T group. Concentrate
FI (%DM) was significantly higher in T group overall the trial period, while
ADG, FCR and milk replacer FI (%DM) were not influenced by probiotic
administration. GHS showed increased mean value, but non significantly, in T
group (T=20.45 vs C=18.91). Increased haemoglobin (10.04g/dl vs 8.60g/dl) and
hematocrit (26.68% vs 22.17%) plasma content at 8d in T group with lower
eosinophils percentage (0.05% vs 0.22%) were found at 8d in T group, while
basophiles content was increased at 28d in species-specific probiotc-fed animals
than C (0.21% vs 0.16%, respectively; P<0.05). The administration of a species-
specific probiotic compound during the first month of life of newborn calves
improved gut microflora, increased performance and some biometric parameters.
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4.2 Introduction
Calf health is a critical factor linked to the economics of intensive breeding: not
only health in the first weeks of life is strictly linked to the mortality rate, but also
to the impact on morbidity with increased antibiotic and feed costs, couples with
reduced animal growth performance. In the first month of life, calves possess an
extremely unstable intestinal microflora (Postema et al., 1987; Lucàs et al., 2007)
and are easily susceptible to the proliferation of pathogenic microorganisms: as a
consequence they are frequently subjected to gastrointestinal diseases, in
particular to episodes of diarrhoea. Many of the problems that affect the
performance of young calves are indeed related to low digestion and reduced
absorption of nutrients due to gut colonization of pathogens (Signorini et al.,
2011). Healthy animals have a equilibrate and balanced intestinal microflora, in
particular the intestinal tract is colonized by microbiota that develop in a
beneficial symbiosis with the host (Kurzak et al., 1998), allowing an optimal
growth rate. The treatments, frequently used to contrast calf diarrhoea and
intestinal diseases, are often based on antibiotics or other antimicrobial agents.
The use of mass antibiotic treatments in livestock determined serious and
alarming consequences such as the development of antimicrobial resistances
among the microbial population. Lactic acid bacteria, usually found in the
intestinal microflora of humans and animals (Schneider et al., 2004) are widely
recognized for their beneficial properties such as the balance of the gut
microorganisms, the inhibition of pathogenic bacteria colonization and the
improvement of Gut-Associated Lymphoid Tissue (GALT) (Corcionivoschi et
al., 2010; Morrison et al., 2010; Riddel et al., 2010). It is well known that feeding
probiotic to calves determine an improvement of gut health. The subsequent
positive effect leads to an increase in digestion efficiency and consequently to
better growth performance (Timmerman et al., 2005; Frizzo et al., 2010;
Kawakami et al., 2010). In addition, the higher effectiveness of the use of
multispecies-multistrain probiotics was demonstrated than that of monostrain
products (Timmerman et al., 2005), thanks to the synergism of different
mechanisms of action (Timmerman et al., 2004). The aim of this study was the
evaluation of the effects of the administration of a multispecies-multistrain
species-specific probiotic, previously developed (Ripamonti et al. 2011), to
newborn Friesian female calves in the first month of life, with particular interest
on gut microbial health, general health status, growth performance,
haematological parameters and immune mediate cell response.
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4.3 Materials and Methods
4.3.1 Experimental design and administration of probiotic
A total number of 22 newborn Friesian female calves, were divided into 2
different groups: Control group (C), fed with a standard
milk replacers/concentrates diet, and Treated group (T), fed with the same diet
supplemented with 1g/die of a species-specific multistrain probiotic powder
(Lactobacillus animalis-Lactobacillus paracasei-Bacillus coagulans, 30:35:35% with final
concentration of 1,8x1010 CFU/g). Calves were randomly assigned to treatments
and were started on probiotic intake by 2nd day of age. Each calf was placed into
individual outdoor box sized 2x1.25 m in order to prevent cross contamination.
The trial lasted for the first 28 days of life and occurred in the months between
January and June 2011. Calves were fed individually twice a day (7.00am-
17.00pm) starting from the second day of life, with non-medicated milk replacer
(MR) containing 22.5% of crude protein, 18% of fat, 9.0% of ashes, 1.75% of
lysine, 0.55% of methionine and 0.50% of cystine. The milk powder (130g/L)
was reconstituted in hot water (65°C) and fed at a temperature of 39°C in the
bucket. The initial powder administered amount was on average 393 g/head/d,
while the final was 514 g/head/d. Quantitative of milk replacer refused by a
single calf were measured at each feeding. At the same time a commercial
pelleted starter mixture (SM) composed by wheat bran, soybean meal, corn flake,
corn flour, corn gluten feed, sunflower meal, dried beet pulp, cane molasses and
mineral-vitamin supplementation, was offered ad-libitum from a bucked once
daily. The starter chemical composition on DM basis was: 20.28% crude protein,
4.38% crude fat, 8.46% crude fibre, 30.01% neutral detergent fibre (NDF) and
8.37% ashes. The total refusal of SM was quantified at the end of the trial. Water
was ad libitum available since the second day of life.
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4.3.2 Microbiological and gut health markers
Faecal samples on day 2, 8, 14, 21 and 28 of life were collected from each female
calf by rectal stimulation, stored in vials with transport medium (Faecal TM
enteric Plus, Oxoid, Basingstoke, UK) kept refrigerated (4°C) until delivered to
the laboratory and analyzed the same day. Ten grams of each sample were
diluted with 90 mL of Buffered Peptone Water (Oxoid) and homogenized in a
Stomacher for 1 min (Seward Stomacher 400 blender Mixed Homogenizer,
International PBI, Milano, Italy). Serial 10-fold dilutions were plated onto MRS
agar medium (Oxoid) and TBX agar (ISO 16649-2) (Oxoid) for the enumeration
of lactobacilli and Escherichia coli, respectively. MRS agar plates were incubated in
anaerobic jars (Anaerojar, Oxoid) with Anaerogen kit (Oxoid) at 37°C for 48 h,
while TBX agar plates were incubated aerobically at 44°C for 24 h. After
incubation, the agar plates were assessed for growth and typical colonies were
counted. Individual faecal scores were measured daily on a scale of 1 to 5 (1 =
watery, 5 = firm; Zaaijer and Noordhuizen, 2003), from 2 to 27 days. General
health score (GHS) was calculated using the formula performed by Timmerman
et al. (2005) modified as following: 28-(1×total number of diarrheic days)−
(2×number of individual therapeutic treatments for digestive diseases) −
(3×number of individual therapeutic treatments for respiratory diseases) −
(2×number of individual therapeutic treatments for infections other than
digestive or respiratory) − (2×number of antibiotic treatments on a herd basis).
4.3.3 Growth performance
Milk replacer intake was registered daily throughout the experimental period,
while the starter consumption was recorded daily by the difference between
offered amount and total daily refusals. Starting from daily intake of milk
replacer, the intake of air-dry milk replacer was calculated as (milk offered- milk
refused) x inclusion rate of dry-air milk replacer per litre of water. Body weight
was recorded weekly by an electronic weighing system (model BF/E 1425E) and
ADG and FCR were subsequently calculated. At 2, 8, 14, 21 and 28 days after
birth biometric parameters, such as hearth girth (HG), body length (BL), withers
height (WH) and hip width (HW) were measured by a calibrated meter according
to Hoffman (1997).
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4.3.4 Haematological parameters
Haematological parameters were determined at 2, 8, 14, 21, and 28 days of life:
two tubes of blood were drawn from the jugular vein of each animal into 10ml
lithium heparin vacuum tubes (Terumo Venosafe 10 ml VF-109SHL, Terumo
Europe L.V., Leuven, Belgium). All tubes were immediately placed on ice and
transferred to the laboratory. Blood samples were processed using an auto-mated
veterinary haematology analyzer (Nihon Kohden, Cell Tac a, MEK 6108, Tokyo,
Japan) for the determination of hematocrit (HCT), red blood cells count (RBC),
mean cell volume (MCV), haemoglobin (HB), mean cell haemoglobin (MCH),
mean cell haemoglobin concentration (MCHC), platelets (PLT), platelet
distribution width (PDW), mean platelets volume (MPV), percentage of large
platelets (PLCR), plateletcrit (PCT), neutrophils, red cells distribution width
(RDW), lymphocytes and monocytes. Moreover white blood cell count (WBC),
basophiles, neutrophils and eosinophils content was assessed in whole blood
samples with a Hemat 8 (SEAC, Calenzano, Florence, Italy).
4.3.5 Skin test
Cell-mediate immune response was evaluated determining double skin thickness
in response to phytohaemoagglutinin injection (PHA, Sigma Chemicals, St.
Louis, MO, USA) using the test procedure described by Lacetera et al. (1999).
The test was performed at 8 and 28 days after birth, in either instance succeeding
intradermal injection of 250 µg PHA diluted in 0.1 ml of sterile PBS (Sigma) to a
top-part shaved area of right shoulder using an automatic syringe for intradermal
injection (Veterinaria Strumenti, Padova, Italy). Sterile PBS (0.1 ml) was injected
to the corresponding area of left shoulder in order to check any skin response to
PBS alone. Double skin thickness to both areas was measured with a constant
tension caliper (Mitutoyo Italiana, Lainate -MI-, Italy) before (time 0) and 24
hours after PHA injection. Values obtained at 24 h were considered the
maximum PHA response (Lacetera et al., 1999).
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4.4 Statistical analysis
Data relative to growing performance, microbiological markers, blood
parameters, faecal score, skin test at 8 and 28 days of life were processed by a
mixed procedure of SAS 9.2 (SAS INSTITUTE SAS Inc, NC, USA). The
statistical model included the following main effects and interactions: treatment,
day of treatment and treatment by day of treatment. Probability values P>0.05
were considered non-significant. All data in the text and tables are presented as
least square means ± s.e.
Yij = µ + Ti + Dj + (T x D)ij + eij
Where µ= general mean; Ti= effect of ith treatment (i=1-2); Dj= effect of day of
treatment; (TXD)ij = effect of the interaction between treatment and day of
treatment; eij = casual effect of each observation.Data relative to milk replacer
and concentrate feed conversion rate, general health score and total skin
thickness were analysed by a General Linear Model procedure of SAS 9.2 (SAS
INSTITUTE SAS Inc, NC, USA).
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4.5 Results
4.5.1 Microbiological parametersin feces, faecal score, and general health
status
Faecal E. coli and Lactobacilli counts were not significantly different in the two
experimental groups even if a trend to lower content of E. coli was found in T
group at 28 days of life (C=5.01; T=3.76 Log CFU/g) (Tab1). As a sum of
effects Lactobacilli/E. coli ratio showed higher values in T group at the end of
the trial, ( T=3.73 vs. C=2.02; P<0.05) (Fig.1).
TIME GROUP P
ITEM (Day) C T SEM GROUP TIME G*T
E. Coli
(LogUFC/g) 2 6.28 5.72 0.48 0.16 <0.01 0.53
8 5.34 5.05
14 4.12 4.55
21 4.49 3.96
28 5.01 3.76
Lactobacilli
(LogUFC/g) 2 7.91 7.71 0.39 1.00 <0.01 0.62
8 8.46 8.08
14 7.75 7.71
21 7.53 7.64
28 7.03 7.49
Tab 1: Lactobacilli and E. coli counts in control (C) and treated (T) groups
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Figure 1: Lactobacilli/E. coli ratio in control (C) and treated (T) groups (*P< 0,05)
Faecal score showed significantly higher values in T group at 6 (C=1.82 vs
T=2.64; P<0,05), 25 (C=2.00 vs T=2.91; P<0.01), and 27 days of life (C=2.36 vs
T=3.09; P<0.05) (Fig. 2), while GHS was not influenced by the treatments
althought numerically a higher mean value was detected in T (T=20.45 vs
C=18.91)
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Figure 2: Trend of faecal score (FS) in treated (T) and control (C) groups (**P<0.01;*P < 0.05)
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4.5.2 Growth performance
All calves were healthy during the trial and no animal deaths were registered.
Increased BW (Tab. 2) was found in T animals than C at the end of the trial
(48.92 kg vs 46.92 kg; P≤0.04), while no differences were detected between
groups on biometrical parameters, with the exception increased mean HG in T
group (81.16 cm vs. 78.49 cm; P≤0.05). The total milk replacer intake was not
different between the two experimental groups, while total concentrate intake
was higher in treated group (14.77kg vs 12.56 kg; P<0.05) than C. FCR was not
found to be different between C and T.
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Table 2: Growth performance in treated (T) and control (C) groups (A,B P<0.01; a,b P<0.05)
TIME GROUP P
ITEM (Day) C T SEM G T G*T
Body weight
(kg/head) 2 39.40 39.92 0.56 0.12 <0.01 0.31
8 41.49 40.86
14 41.84 43.06
21 43.80 44.72
28 46.92b 48.92a
Biometric Measurements
Withers height (cm) 2-28 79.65 79.85 1.35 0.80 <0.01 0.98
Hearth girth (cm) 2-28 78.49b 81.16a 1.26 0.01 <0.01 0.99
Hips width (cm) 2-28 22.49 23.22 0.58 0.05 <0.01 0.87
Body length (cm) 2-28 63.22 62.94 1.51 0.78 <0.01 0.92
Average Daily Gain
(kg/head/day) 2-28 0.42 0.29 0.06 0.54 <0.01 0.16
9-14 0.19 0.34
15-21 0.28 0.29
22-28 0.44 0.52
Total ADG 2-28 0.29 0.37 0.04 0.22
Feed Intake
Milk replacer (g/h/d) 2-28 451.02 449.08 0.83 <0.01 0.99
Calf  starter (tot kg/dm) 2-28 12.56a 14.77b 0.68 0.03
Feed Convers. Rate
Milk replacer+starter 2-28 3.80 3.00 0.37 0.14
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4.5.3 Hematological parameters
Haematological results are reported in Tables 3(a,b) and 4. No differences were
detected during the trial for RBC, MCV, MCH, MCHC, PLT, PDW, MPV,
PLCR, PCT, and RDW. Hematocrit and haemoglobin serum content was
statistically different at 8 days of life (respectively C=22.17% vs T=26.68%,
P<0.05 and C=8.60g/dl vs T=10.04P, <0.05). During the trial HCT content was
slightly below the phisyological limits in both groups in some sampling times,
but these values can be considerate acceptable in very young calves (Riddel et al.,
2010). Lymphopenia, neutrophilia and monocytosis (were detectable in in C and
T animals without any significant diffeence. The values referred to white blood
cell count were within the physiological limits, and no statistical differences were
observed between the groups, except for basophiles at 28 days (C=0.16% vs
T=0.21%;P<0.05) and eosinophils at 8 days (C=0.22% vs T=0.05%; P<0.01).
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TIME Group P
ITEM (Day) C T SEM GROUP TIME G*T
Hct 2 23.79 27.08 1.46 <0.01 <0.01 0.97
(%) 8 22.17b 26.68a
14 22.04 24.61
21 20.46 23.52
28 28.32 21.69
Rbc 2 6.33 7.00 0.41 <0.01 <0.01 0.973
(M/µl) 8 6.12 7.07
14 6.09 6.54
21 5.47 6.25
28 4.81 5.76
Mcv 2 37.67 38.78 0.59 0.05 0.07 0.36
(fl) 8 36.23 37.84
14 36.34 37.61
21 37.62 37.89
28 38.50 37.97
Hbg 2 8.80 9.93 4.65 <0.01 0.74 0.93
(g/dl) 8 8.60b 10.04a
14 8.67 9.54
21 8.59 9.27
28 8.44 9.29
Mch 2 14.14 14.41 0.74 0.71 <0.01 0.73
(pg) 8 14.10 14.49
14 14.27 14.80
21 16.04 15.38
28 18.06 16.84
Mchc 2 37.49 37.24 1.58 0.25 <0.01 0.93
(g/dl) 8 38.99 38.26
14 39.60 39.26
21 42.47 40.51
28 46.62 44.13
Table 3a: Haematologica parameters in control (C) and treated (T) groups (A,B P<0.01; a,b P<0.05)
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TIME GROUP P
ITEM (Day) C T SEM GROUP TIME G*T
Plt 2 606.64 543.18 59.58 0.49 <0.01 0.80
(k/µl) 8 758.33 823.45
14 702.09 743.70
21 647.18 677.20
28 519.73 576.50
Pdw 2 72.40 75.60 2.74 0.18 <0.01 0.94
(fl) 8 69.85 74.36
14 66.82 67.12
21 65.90 67.55
28 66.00 67.83
Mpv 2 64.50 64.90 1.13 0.61 <0.01 0.99
(fl) 8 62.86 63.36
14 59.63 60.37
21 59.20 59.89
28 60.17 59.67
Plcr 2 43.80 49.70 4.92 0.28 <0.01 0.91
(fl) 8 36.00 43.82
14 23.86 25.75
21 23.60 26.33
28 23.50 21.83
Pct 2 39.10 35.50 4.63 0.56 <0.01 0.85
(%) 8 49.57 52.18
14 42.27 47.50
21 36.50 39.33
28 34.33 37.16
Rdw 2 274.64 271.45 6.50 0.92 0.08 0.81
(fl) 8 284.11 285.55
14 294.00 284.90
21 285.64 290.20
28 277.27 281.60
Table 3b: Haematological parameters in control (C) and treated (T) groups (A,B P<0.01; a,b P<0.05)
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TIME GROUP P
ITEM (Day) C T SEM GROUP TIME G*T
Wbc 2 8.66 9.95 0.89 0.96 0.94 0.67
(k/µl) 8 8.98 9.73
14 9.37 8.99
21 9.02 8.39
28 9.42 8.53
Monocytes 2 12.14 10.61 1.55 0.59 <0.01 0.63
(%) 8 9.35 8.74
14 15.65 13.58
21 14.90 15.96
28 16.96 17.44
Limphocytes 2 19.01 22.45 4.12 0.15 <0.01 0.99
(%) 8 22.28 26.90
14 31.10 33.00
21 34.87 37.12
28 38.28 40.88
Basophils 2 0.13 0.16 0.02 0.37 0.07 0.29
(%) 8 0.13 0.14
14 0.16 0.14
21 0.16 0.16
28 0.16b 0.21a
Neutrophils 2 66.64 62.94 4.14 0.28 <0.01 0.99
(%) 8 65.03 62.34
14 51.27 51.01
21 48.34 44.58
28 42.69 38.79
Eosinophils 2 0.10 0.13 0.03 0.70 0.76 0.02
(%) 8 0.22A 0.05B
14 0.04 0.10
21 0.03 0.07
28 0.06 0.07
Table 4: Leukocyte formula in control (C) and treated (T) groups (A,B P<0.01; a,b P<0.05)
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4.5.4 Skin test
There were no differences between the two groups in terms of skin thickness at
PBS injection sites and hence they were not used to correct PHA-induced
thickness. The skin thickness reaction to PHA injection did not increased with
time up to 24 hours post injection in both groups at 8 and 28 days of life (Table
5).
TIME GROUP P
ITEM (Day) C T SEM GROUP TIME G*T
Skin Thickness
(mm) 7 (h24-h0) 0.40 0.65 0.13 0.89 0.12 0.11
28 (h24-h0) 0.48 0.19
Table 5: Skin test in control (C) and treated (T) groups (A,B P<0.01; a,b P<0.05)
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4.6 Discussion
In our study we evaluated the effects of the administration of a species-specific
probiotic compound on gut microbial health, general health, growth
performance, haematological parameters and cell mediate immune response of
newborn female calves in the first month of life. Gut microbial balance is one of
the most important factors which concur to obtain animal health status; its
importance has been underlined in particular for young calves, which immune
system is immature and prone to debilitating diarrhoea and respiratory diseases
(Tsuruta et al., 2009). Oral administration of Lactic Acid Bacteria (LAB)
probiotics has been already recognized as a promoter of intestinal microbial
balance and growth performance (LeJeune and Wetzel, 2007; Al-Saiady, 2010;
Hossaini et al., 2010, Kawakami et al., 2010, Nagashima et al., 2010). The
beneficial effects of probiotics are possibly due to the transient proliferation in
the digestive tract, developing a microbial defense against the proliferation of
pathogenic bacteria; in particular lactic acid bacteria are recognized to be
effective against Escherichia coli and Salmonella spp. In our trial we considered
Lactobacilli and E. coli counts as microbiological indicators of gut microbial
health: their role has been already underlined by other authors, who detected
clearly higher Lactobacilli/coliforms ratio in healthy calves than in calves
suffering from diarrhoea (Abu-Tarboush et al., 1996; Frizzo et al., 2010). Results
from the present trial evidenced a better Lactobacilli/E. coli ratio, indicating a
favourable equilibrium in the microflora of these animals, especially during the
last phase of the trial in agreement with Timmerman et al. (2005), and Stella et al.
(2007) but in goats, and Frizzo et al. (2011) in calves who underlined a higher
Lactobacilli/coliforms when supplementing LAB inoculums. The improved gut
health status observed in our study was confirmed by increased faecal score in T
group with a lower frequency of episodes of diarrhoea in agreement with
Kawakami et al. (2010). Although GHS was not different between the
experimental groups, numerically higher values could suggest a healthier status
of T calves. as reported by Timmerman et al. (2005). The improvement of
Lactobacilli/E. coli ratio and faecal consistency as indices of health status of the
calves could explain the higher final BW detected in probiotic-fed group as
reported by several authors (Frizzo et al., 2008; Bakr et al., 2009; Al-Saiady et al.,
2010; Hasunuma et al., 2011). In fact it is well known as many troubles affecting
the growth rates are caused by the failure in nutrients digestion and absorption
(Davis and Drackley, 2001). In the present trial weekly ADG tended to be higher
in treated group from the second week of life, confirming data by Timmerman et
al. (2005), Frizzo et al. (2008) and Kawakami et al. (2010) who registered a
significant difference from the second till the fifth week. Calf Starter total feed
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intake was higher in treated group in agreement with some other authors
(Timmerman et al., 2005; Frizzo et al., 2008; Kawakami et al., 2010): this effect is
particularly important, as the dry matter intake in early stage of life is necessary
to assure the proper growth of pre-stomachs, although  the literature reports
inconstant results in different studies (Abe et al., 1995; Bakshi et al., 2006; Frizzo
et al., 2008; Kawakami et al., 2010), probably due to the microorganisms used
and experimental conditions. Haematological profile of veal calves used for the
trial followed generally the physiological trend for the first phases of life.
Considering HCT and HGB, a gradual decrease during the trial was detected.
Such trend could be considered physiological because normally observed from
birth until the first weeks of life of young calves due to the diet composition
(Mohri et al., 2009). The type of delivery is associated to different haematological
profile, having an influence on oxygenation levels and on a-specific immunitary
profile in neonatal calves (Probo et al., 2011). Young calves can also be subjected
to recruitment problems or malabsorption in the first weeks, leading to a
condition of anaemia, defined as a decrease below normal range of RBC, and
HGB (Sarker et al., 2010). In our trial RBC resulted slightly below the normal
range at the third week for C group and fourth weeks for T group, but this trend
should be considered physiological in very young animals. A slight lymphopenia,
associated with monocytosis and neutrophilia was revealed for the whole
experimental period in both groups, but similar values can be usually detected in
very young animals, and do not represent a pathological condition (Mohri et al.,
2011). In the present study HGB levels were significantly higher in T group at 8
days of life; this effect has been observed also in other studies, but literature data
are inconstant and this item should be further investigated (Fleige et al., 2008;
Matsumoto et al., 2009; Al-Saiady et al., 2010; Riddell et al., 2010; Kim et al.,
2011). The reaction to PHA inoculums has been already evaluated in several
species, but till now no trials were conducted on dairy calves supplemented with
probiotic. In our trial no differences in dermal reaction to skin test between the
groups were observed at 8 or 28 days of life. The absence of statistical evidences
in skin test during the first weeks of life have been observed also by Masucci et
al. (2010) in young buffalo calves, evidencing the presence of a positive response
only during later age (11 weeks).
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4.7 Conclusions
The administration of a species-specific multistrain probiotic compound
improved intestinal balance after one month of treatment, consequently
increasing some growth parameters of veal calves na d reducing the incidence of
enteric probems, although a direct effect on cell-mediated immune response was
not observed. Further studies must be conducted to investigate the immune
parameters in neonatal calves, also in different stress conditions
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5 Calcium diformate in calf  diet: effects of  two
different dosages on growing performance,
metabolism, health status, and Ca and formate
organ content
5.1 Abstract
The trial involving 36 male Friesian calves was conducted to determine the effect
of calcium diformate administration and its inclusion level on growth
performance, intestinal balance, metabolism, health status, and calcium and
formate organ content. The calves (44.55kg±5.51kg of body weight, 25±10 days
old), were divided in three homogeneous groups of twelve subjects each: C fed
with a basal diet, T1 fed with a basal diet plus 1%/milk replacer of calcium
diformate, and T3 fed a basal diet plus 3%/milk replacer of calcium diformate
for a total of 84 days of supplementation. During the experimental period daily
Feed Intake (FI), Average Daily Gain (ADG) and Feed Conversion Rate (FCR)
were determined. At 0, 42 and 84 days of trial individual blood samples were
collected in order to detect haematological and biochemical parameters, Ca and
FO content. At the same time faecal samples were collected for Lactobacilli,
total coliforms and E.coli count along with faecal pH. Weekly body weight (BW)
and faecal score (FS) were recorded, while the health status was constantly
monitored and the cause of deaths analyzed by necropsy. At the 91st day of trial
the calves were slaughtered: any presence of ulcers were detected, individual
carcass weight and dressing percentage were determined, and kidney and liver
weight recorded. On seven animals per group liver, kidney, muscle and fat
samples were collected and total Ca and formate were evaluated. The
administration of calcium diformate decreased dry matter intake from either milk
powder, concentrate and both milk powder and concentrate together with
increasing level of calcium diformate in the diet (C=1419,05g/h/d;
T1=1217,78g/h/d; T3=1190,73g/h/d; P≤0.01). As a result, final body weight in
treated animals was lower than control calves (C=121,00kg; T1=112,17kg;
T3=108,74kg; P≤0.01). Mean ADG in 3%/milk replacer CaFO calves was
decreased if compared to C subjects (C=0.87kg/h/d vs T3=0.73kg/h/d;
P<0.01), while a similar feed conversion rate was detected between the
experimental groups. Faecal score was decreased in T3 animals (P≤0.05) than
control while no differences were found for faecal pH, E.coli or Lactobacilli.
Higher total coliforms count was evidenced in T1 animals than C (7.45 Log10 vsT1=2.75Log10 respectively; P≤0.05).
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 At slaughter no difference was observed for dressing percentage, while carcass
weight resulted higher in C compared to T3 (C=67.49kg vs T3=58.87; P≤0.05).
Organ weight and organ formate and calcium content were similar between the
experimental groups.
Red blood cells count (RBC), haemoglobin (HB) and hematocrit (HT) resulted
higher (P≤0.05) in C and T3 than T1, while control calves showed higher
platelets (P≤0.05) value than T1, and greater (P≤0.05) triglycerides than T3.
Mean cell haemoglobin (MCH) value resulted higher (P≤0.05) in T3 subjects
than the other groups. Increased formate blood content in 3% of calcium
diformate/milk replacer animals did not show any differences for organ formate
content thus giving no accumulation. Immune response was not affected by the
treatment and necropsies on dead animals suggest no interaction among
treatment and death itself. The histological examination revealed altered
structural aspects of the intestinal mucosa in all the experimental corresponding
with no detectable differences between control T1 and T3 groups. Epithelial
detachment in the intestinal villi associated with mucous secretion excess and
some diffuse mixed cellular infiltration sub mucosa and lamina propria were
highlighted. The sub mucosal Brunner glands were in normal physiological
conditions in C, but showed empty and enlarged lumen in treated animals. While
not showing toxic effects in veal calves, the administration of calcium diformate
is not useful in promoting the growth performance and gut balance. In
conclusion the calcium diformate supplementation, even if not showing toxic
effects in veal calves, isn’t helpful to increase the intestinal microbial balance and
the growth performance.
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5.2 Introduction
Feeding practices, composition of animal diets and farm management can
influence the microbial balance in the gastrointestinal tract and, subsequently,
affect feed efficiency and the animal health.
Under current husbandry conditions, veal calves are often affected by diarrhoea,
which is the main cause of morbidity and mortality in the early life of veal calves
(Timmerman et al., 2005).
Immunity against pathogen and viruses begins with the dam. Calves are born
with an immune system that is naive, and must be “taught” before it is able to
respond fully to pathogenic challenges on its own. Various factors can cause the
high incidence of intestinal and respiratory diseases in veal calves: after birth
calves are separated from their mothers, preventing the calf from picking up the
protective gut microflora from (Fuller, 1989). The second and the third week of
life have been found to be the most critical in terms of calf mortality and they
could be viewed as a “weak” period, where the effectiveness of passive immunity
is lessening and adaptive immunity is not fully functional (Wilde, 2008).
Furthermore, at young age, the calves are faced with major stress events like
transportation, dietary changes and exposure to a variety of infectious agents.
Subsequently, animals are predisposed to the loss of the barrier function on the
gut (Nabuurs et al., 2001; Soderholm and Perdue, 2001), and may suffer from
impaired immune function (Timmerman et al., 2005). Moreover, the protective
potential of the microbial gut flora tends to decrease (Cray et al., 1998).
Thus, a preventive intervention is the recommended strategy. As a preventive
measure alternative to use of antibiotics, acidifiers are recommended (Palenzuela
et al., 2003; Ribeiro et al., 2009) due to their bacteriostatic and bactericidal action
(Young and Foegeding, 1993).
Organic acids have been used for decades in commercial compound feeds,
mostly for feed preservation, where formic and propionic acids are particularly
effective. In the European Union, several organic acids and their salts (e.g.,
calcium formate, calcium propionate) are used under the classification “feed
preservatives”. Acidifiers are the most reliable product group of the non-
antibiotic growth promoters available in Europe, and can also be used safely and
effectively with other additives (Lückstädt et al., 2011).
Acids added to diets may provide benefits through maintaining a low gastric pH
that may increase nutrient digestion and reduce pathogen survival (Mroz, 2003;
Kim et al., 2005). The main mechnaism of action of organic acids is through
their antimicrobial effects, the magnitude of which is dependent on the chemical
properties of the individual acid or acid salt.
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Briefly, the undissociated organic acids are lyophilised, so they can cross the cell
membrane of Gram negative bacteria such as Salmonella. Once inside the cell, the
higher cytosolic pH causes the acid to dissociate, releasing hydrogen ions, which
subsequently reduces the intracellular pH. Microbial metabolism depends on
enzyme activity, which is depressed at lower pH. To redress the balance, the cell
is forced to use energy to expel protons out across the membrane. Over a period
of exposure to organic acids, this can be sufficient to kill the cell. Lactic acid
bacteria are less sensitive to the pH differential across the cell membrane, and,
thus, they remain unaffected (Lückstädt et al., 2011). Therefore, the
improvement in growth performance resulting from dietary inclusion of organic
acid salts is due to an antimicrobial effect (Kirchgessner et al., 1992). Formic acid
is added to the diets in the form of its salt (K e Ca), which results more
manageable than pure form and more efficient to promote the growth
performance (Paulicks et al., 1996; Kirchgessner et al., 1997). The administration
of formic acid salts leads to a higher digestibility of the diet (Roth et al., 1998)
especially when milk replacers contain lower levels of milk by-products (Lawlor
et al., 1992): the acid lactic production induced from lactose can decrease the
stomach pH masking the acidificant effects of the formate.
A high calcium formate inclusion in the diet can give rise to toxicity
phenomenon in dairy cows (Scott e Van Wijk, 2000), while further trials should
be conducted with relation to calves.
The aim of the trial was to evaluate the effects of two different dietary dosages
of calcium diformate on growing performance, metabolism, health status, Ca and
formate organ content in veal calves.
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5.3 Materials and methods
5.3.1 Animals and Experimental Design
A total number of 36 Friesian male calves coming from different farms (25±10
days old, body weight of 44.55±5.51kg) were divided into three homogeneous
groups on the basis of initial BW on the 7th day  from arrival. The subjects were
allocated to six different boxes (two boxes for each treatment) and received the
correspondent experimental dietary treatment consisting of a basal diet (C
group) plus 1%/milk replacer of calcium diformate (T1 group) or 3%/milk
replacer of calcium diformate (T3 group). The test had two main phases named
F1 and F2 respectively. F1 lasted for 7 days (adaptation period, no experimental
treatment was performed) and F2 lasted for 84 days (days 8-91), during which
the groups received the correspondent dietary treatment, for a total of 91 days of
the experimental study. During the first seven days after the calves’ arrival, the
basal diet was administered and no measurements were performed in order to
reduce the animal stressors, except for feed records. The calves were allotted
indoor with environmental contrled conditions and reared on concrete slatted
floor with straw. each experimental box had the same area of approximately
17.50 m2 , with a density of 2.9 animals/m2 each box was equipped with
individual buckets and feeders in order to determine milk and feed consumption.
Experimental animals were fed twice a day at 07:00am am and 6.00pm, In the
first 47 days from the arrival a prestarter milk powder type was administered,
while a starter type was provided from 48th day up to the end of the trial (Tab.1
and 4). The milk powder was mixed with hot water at a temperature of 70°C and
a concentration of 110g/L at the beginning of the trial, 125g/L until 60 days of
treatment and 140g/L subsequently. Increasing milk replacer amounts were
administered according with the standard procedures related to the age of the
animals. The meal was administered approximately at 38°C, controlled with an
electronic thermometer. The calves initially received 2L/head/meal, increased of
0.5L/head/meal weekly for a total of 8 litres per meal at the end of the trial.
The provided commercial concentrate, composed by 50% of corn grain and
50% of corn silage (Tab.1) was administered once a day (12.00am) starting from
the 14th day from arrival at the initial rate of 50g/head/day until 250g/head/day
at the end of the experimental period. The orts were removed, weighed and
recorded at each meal.
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During the supplementation period the administered diets were adjusted for an
equal Ca content (Tab.2 and 3).The experimental premix was prepared weekly in
order to include the proper amount of CaCO3 and calcium diformate in the
respective diets (Tab.2 and 3).
Calves had free access to drinking water at all times and the experimental diets
were able to meet the requirements stated by the NRC for the different stages of
growth.
** Milk powder and concentrate provided by Zoogamma s.p.a. (VanDrie Group. Borgo
Satollo, Ghedi, Brescia)
Chemical analysis (%DM) Milk PowderPrestarter
Milk Powder
Starter Concentrate
Moisture        7.00      8.70 42.31
Crude protein      22.04    21.14 12.96
Crude fat      18.17    19.06   4.41
Ash        7.05      7.97   4.25
Crude Fibre --- ---   7.55
NDF --- --- 20.50
Starch --- --- 76.32
Ca        0.43       0.41 ---
Ptot        0.70       1.27 ---
Formic acid        0.04 ≤0.01 ---
DE(kcal/kg) 4,800.00 4,783.00 ---
ME(kcal/kg) 4,670.00 4,665.00 ---
Table 1: Composition and chemical analysis of the calves concentrate, prestarter and starter milk
powder diet without any addition of  CaCO3 and of calcium diformate.
Prestarter Starter
Group Premixa MilkPowdera
Ca from
premixa
Ca from
 milka
Total Ca
Contentb
Ca from
milka
Total  Ca
contentc
C 2.53 97.47 0.936 0.360 1.30 0.361 1.30
T1 2.69 97.31 0.936 0.360 1.30 0.360 1.30
T3 3.00 97.00 0.936 0.359 1.30 0.359 1.30
(Prestarter Calcium Content, %a.f.=0.61; Starter Calcium Content, %a.f=0.37)
Table 2: Inclusion of experimental premixes in milk powder and target Ca content (calculated)
in the diet of veal calves (a=kg a.f; b= kg/100kg a.f.; c=g/100kg a.f.)
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Table 3: Composition of experimental premixes and calculated Ca target content
Table 4: Analyzed chemical composition of the experimental milk powders (%DM).
Group
Calcium
diformate
(g)
Ca
From Ca
Diformate(g)
CaCO3*
(g)
Ca
from
CaCO3 (g)
Total
amount
 of premix
(g)
Total Ca
amount
(g)
C --- 0.00 2,529.73 936.00 2,529.73 936.00
T1 1,000.00 312.00 1,686.48 624.00 2,686.48 936.00
T3 3,000.00 936.00 --- 0.00 3,000.00 936.00
C T1 T3
Chemical analysis
(%DM) Prestarter Starter Prestarter Starter Prestarter Starter
Moisture 7.10 7.50 7.80 8.00 7.30 6.40
Crude protein 21.85 19.78 22.56 19.57 21.79 19.55
Ether extract 18.41 18.16 18.44 18.37 18.34 17.95
Ash 9.10 10.30 9.24 10.08 9.06 9.44
Ca 1.26 1.45 1.19 1.26 1.24 1.38
P tot 0.86 0.89 0.78 1.00 0.78 0.92
Formic acid 0.04 ≤0.01 0.74 0.74 2.46 2.44
DE(kcal/kg) 4,560.00 4,408.00 4,594.00 4,431.00 4,570.00 4,366.00
ME(kcal/kg) 4,439.00 4,308.00 4,467.00 4,332.00 4,449.00 4,267.00
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5.3.2 Growth performance and feed analyses
Initial individual body weight (BW) was evaluated upon arrival. Subsequently the
individual BW was recorded weekly with an electronic weighing scale (sensitivity
100 g).
Starting from day seven, ADG was calculated and FCR estimated based on a
daily individual total dry matter intake (milk replacer and concentrate
consumption) (DMI).
On the seventh day from test beginning, the prestarted milk powder type was
collected and subsequently analyzed for dry matter content (DM), raw protein
content (CP), fat content (EE), ash content, calcium (Ca) and phosphorus (P)
and for the starter type on 48th day of trial.
On the 14th day from the start, the concentrate was sampled for dry matter
content, protein content, fat content, ash content, NDF value calcium and
phosphorus. A sample of the concentrate given to the animals on 14th day from
arrival was analyzed for DM, CP, EE, ash, NDF, Ca and P content.
5.3.3 Haematological parameters
On  days 0 (7th day from arrival), 42 and 84 of the treatment, individual blood
samples taken from the jugular vein were collected into three 10 ml vacuum
tubes (Terumo Venosafe 10 ml VF-109SHL, Terumo Europe L.V., Leuven,
Belgium). The tubes were immediately placed in ice, transferred to the laboratory
and automatically analyzed by Sysmex 2000i (Sysmex corporation) for red blood
cells count (RBC), haemoglobin (HB), hematocrit (HT), reticulocytes,
reticulocytes production index (RPI), mean cell volume (MCV), mean cell
haemoglobin (MCH), mean cell haemoglobin concentration (MCHC), red cells
distribution width (RDW), platelets (PLT), mean platelets volume (MPV),
plateletcrit (PCT), platelet distribution width (PDW), white blood cell (WBC).
The leucocytes formula (neutrophils, limphocytes, monocytes, eosinophils and
basophils) was assessed in whole blood samples with a Hemat 8.
The samples were further analyzed for some blood chemical parameters:
albumin, alkaline phosphatase (ALP), alanine aminotransferase (ALAT), gamma-
glutamyl transferase (GGT), creatinine, glucose, total cholesterol, triglycerides,
total protein, bilirubin, urea, uric-acid, iron (Fe), magnesium (Mg), phosphorus
(P) determined by Cobas ® Mira Classic (Roche Diagnostics).
Moreover haptoglobin, pepsinogen calcium (ISTISAN 1996/34) and formic acid
(MI 397 rev 0 2007) were determined in collected blood samples.
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5.3.4 Faecal parameters and gut microbial balance
On days 0 (7th day from arrival), 42 and 84 of the treatment, faecal samples
from six animals per group were collected by rectal stimulation, stored in vials
with transport medium (Faecal TM enteric Plus, Oxoid, Basingstoke, UK) kept
refrigerated (4°C) and analyzed in order to determine the Lactobacilli count (ISO
15214:1998), E.coli count (ISO 16649-2:2001), total coliforms (ISO 4832:2006)
and faecal pH.
The individual faecal score was recorded weekly on a scale of 1 to 5 (1 = watery,
4 = firm; Larson et al., 1978), and diarrhoea incidence was calculated.
5.3.5 Health Status
During the whole trial, the health status was checked and recorded daily; signs of
toxicity and illness were recorded, unexpected deaths were necropsied.
The occurrence of diarrhoea was evaluated daily.
5.3.6 Slaughter Parameters and Intestinal morphology
At the end of the trial (91 days after arrival, 84 days of treatment) the individual
carcass weight and dressing percentage were evaluated at the slaughterhouse;
moreover, the individual liver and kidney weight were determined. The presence
of gastrointestinal ulcers was individually detected at necropsy.
On 8 animals per group liver, kidney, muscle and fat samples were collected and
total Ca were evaluated by atomic absorption with spectrophotometer (ISTISAN
1996/34) and formate content were determined by Boehringer Mannheim/R-
Biopharm (R-Biopharm AG Landwehrstr.54 D-64293, Germany) modified kit
for tissues as suggested from the producer.
Eight calves for each group were selected at slaughtering for histomorphological
analysis. The entire intestine was removed and fragments of proximal duodenum
were sampled from each animal and promptly fixed in 4% paraformaldehyde in
0.01 M phosphate buffered saline (PBS) pH 7.4 for 24 h at 4°C. The specimens
were then dehydrated in graded alcohols, cleared with xylene and embedded in
paraffin. After dewaxing and rehydration, serial microtome sections (4-µm thick)
were stained with Haematoxylin-Eosin (HE) sequential staining to ascertain
structural detail.
Histometric evaluation was used to determine 10 villous height (V), 10 crypts
depth (C) and the relative villous height to crypt depth ratio (V:C) per section.
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5.3 Statistical analysis
Body weight, ADG, FI, haematological, microbiological analyses and faecal
parameters were analysed by a MANOVA procedure for repeated measures of
SAS/STAT (Version V8, 1999, SAS Inst, Inc., NC, U.S.A.), including the fixed
effect of treatment, the day, and the interaction treatment per day considering
the animal as the experimental unit.
Carcass weight, dressing percentage, organs weight and their Ca and Fo content
were analysed by a General Linear Mode (GLM) procedure of SAS/STAT
(Version V8, 1999, SAS Inst, Inc., NC, U.S.A.) including the fixed effect of
treatment and considering the animal as the experimental unit. The significance
was declared at P≤0.05.
Histometric data (villous height, crypt depth, V:C ratio) were analysed through
ANOVA using the mixed procedure of the SAS package. The model included
treatment as fixed effect and the calves as random effect. The data were
presented as least squared means ± SE. Differences between least squared
means were analysed by orthogonal contrast and considered significant at P
<0.05.
5.4 Results
5.5.1 Growth performance
The growth performances during the trial in veal calves are reported in Table 6
(a,b and c). No differences in BW were detected among experimental groups at
the beginning of the trial; while at the end, T1 animals evidenced a lower BW
compared to C animals (C=121.00kg; T1=112.17; T3=108.74; P≤0.01). During
the experimental period, starting from the first week of treatment, both T1 and
T3 groups significantly decreased BW in comparison with C animals; whilst no
differences were observed among the treated groups.
As early as the 5th week of supplementation and until the end of the trial, milk
powder DMI was statistically lower in both T1 and T2 groups than in control.
The same trend was observed for concentrate DMI from the 8th considered
week; while no difference was detected among the treated animals. As a result,
total DMI significantly decreased from the fifth week of administration
(C=1,419.05g/h/d, T1=1,217.78 g/h/d, T3=1.190,73 g/h/d; P≤0.01).
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The supplementation significantly reduced the total ADG in T3 compared to C
(0.73kg/d vs. 0.87kg/d respectively; P≤0.01); the same trend was observed in
both T1 and T3 groups during the 1st and the 6th week of supplementation and
also at 8th week in T3 subjects.
Considering all the trials, no influence of calcium diformate administration was
determined on FCR calculated on milk powder, concentrate or both pooled
togheter. Differently, at 2nd,6th  and 9th week from the beginning of the
supplementation of calcium, the feed efficiency calculated on the milk powder
given to C subject  improved significantly in comparison with what recorded for
the animals in T3. An opposite trend could be seen during the third week of trial
compared to the third observed time.
Both total FCR and FCR calculated over milk supllementation were similar in
groups T1 and T3, except for a lower value in T3 detected at week 9 from the
beginning of treatment.
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Table 6a: Growth performance in veal calves during the weeks of the trial
(A,B,C= P≤0.01; a,b=P≤0.05)
TIME GROUP P
ITEM (week) C T1 T3 SEM GROUP TIME G*T
DMI 2 672.86 651.33 653.14 40.43 0.01 0.01 0.01
Milk P. 3 793.63 771.19 769.15
(g/h/d) 4 907.77 849.56 866.08
5 1,042.14a 984.77 920.68b
6 1,261.08Aa 1,133.90Ab 934.13B
7 1,443.00A 1,217.47Ba 1,078.27Bb
8 1,538.58A 1,188.33B 1,213.99B
9 1,634.94A 1,313.30B 1,399.32B
10 1,763.67A 1,347.80B 1,304.78B
11 1,752.88A 1,477.37B 1,589.33B
12 1,959.46A 1,669.80B 1,601.50B
2-12 1,342.73A 1,145.89B 1,120.94B 12.07 <0.01
DMI 2 22.90 20.71 21.44 2.56 0.01 0.01 0.01
Concen. 3 31.53 30.53 31.85
(g/h/d) 4 39.80 41.09 37.74
5 58.26 56.28 55.51
6 70.33 67.00 67.39
7 81.19 82.21 79.05
8 88.23A 78.79B 83.66
9 99.73Aa 89.27B 92.43b
10 106.01A 95.39B 96.35B
11 118.21A 106.78B 95.93C
12 123.34A 122.68A 106.30B
2-12 76.32A 71.88B 69.79B 0.76 <0.01
Total 2 695.77 672.04 674.58 42.29 0.01 0.01 0.01
DMI 3 825.16 801.71 800.99
(g/h/d) 4 947.57 890.64 903.82
5 1,100.41a 1,041.05 976.19b
6 1,331.42Aa 1,200.90Ab 1,001.51B
7 1,524.18A 1,299.67Ba 1,157.32Bb
8 1,626.81A 1,267.12B 1,297.65B
9 1,734.67A 1,40257B 1,491.75B
10 1,869.67A 1,443.19B 1,401.14B
11 1,871.08A 1,584.14B 1,685.26B
12 2,082.80A 1,792.48B 1,707.80B
2-12 1,419.05A 1,217.78B 1,190.73B 12.56 <0.01
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Table 6b: Growth performance in veal calves during the weeks of the trial
(A,B,C= P≤0.01; a,b=P≤0.05)
TIME GROUP P
ITEM (week) C T1 T3 SEM GROUP TIME G*T
BW 0 48.13 45.25 46.95 1.25 ≤0.01 ≤0.01 ≤0.01
(kg) 1 52.92a 49.75 49.10b
2 56.75a 52.38b 52.80b
3 60.08 56.71 57.30
4 65.79a 62.12b 61.70b
5 71.29Aa 65.38B 66.65b
6 78.63A 71.38B 70.35B
7 86.79A 77.71B 77.35B
8 91.96A 81.92B 79.85B
9 98.96A 88.17B 86.46B
10 106.29A 95.88B 94.07B
11 113.71A 104.25B 101.74B
12 121.00A 112.17B 108.74B
ADG 1 0.68A 0.64a 0.31Bb 0.09 ≤0.01 ≤0.01 ≤0.01
(kg/d) 2 0.55 0.38 0.53
3 0.48 0.62 0.64
4 0.82 0.77 0.63
5 0.79a 0.46b 0.71
6 1.05A 0.86a 0.53Bb
7 1.17a 0.91b 1.00
8 0.74A 0.60 0.36B
9 1.00 0.89 0.89
10 1.05 1.10 1.09
11 1.06 1.20 1.10
12 1.04 1.13 1.00
1-12 0.87A 0.80 0.73B 0.03 <0.01
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Table 6c: Growth performance in veal calves during the weeks of the trial
(A,B,C= P≤0.01; a,b=P≤0.05)
TIME GROUP P
ITEM (week) C T1 T3 SEM GROUP TIME G*T
FCR Milk powder 2 1.18b 1.41 1.76a 0.21 0.20 <0.01 0.018
3 2.08A 1.33B 1.32B
4 1.30 1.14 1.23
5 1.41b 2.10a 1.67
6 1.27B 1.54 2.01A
7 1.32 1.32 1.07
8 2.39 2.35 2.22
9 1.79 1.48b 2.08a
10 1.80 1.31 1.33
11 1.73 1.26 1.74
12 1.95 1.49 1.91
2-12 1.66 1.52 1.66 0.06 0.20
Total FCR 2 1.22 1.45 1.81 0.21 0.22 0.01 0.02
3 2.16A 1.38B 1.37B
4 1.35 1.19 1.28
5 1.48b 2.22a 1.76
6 1.34B 1.64 2.18A
7 1.39 1.41 1.15
8 2.53 2.53 2.37
9 1.90 1.58b 2.21a
10 1.91 1.41 1.43
11 1.85 1.35 1.85
12 2.07 1.60 2.04
2-12 1.75 1.61 1.77 0.06 0.22
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5.5.2 Haematological evaluations
The Haematological result on blood collected samples are reported in Table 7.
and 8. Most of serum parameters were not influenced by the treatments and
were in the suggested ranges for calves (Hege et al., 2006; Mohri et al., 2007).
Red Blood Cells, Hb, and Ht decreased in T1 compared to T3 (RBC and
Ht=P<0.01; Hb=P<0.05) and C (RBC=P<0.01; Hb and Ht=P<0.05) calves, on
the other hand, PLT resulted higher in T1 than in C group (P<0.05). The white
blood cell count in animals fed 3.0%/milk replacer of calcium diformate was
higher in comparison with T1 animals (P<0.05), while MCHC was lower than in
C subjects (P<0.05). Triglycerides content resulted lower in T3 calves than in
Control group (P<0.01), but the mean values was anyway included in the
suggested ranges. ALAT and total protein serum content were found to be lower
than the suggested range in the three experimental groups, while GGT and
haptoglobin were higher. Pepsinogen content resulted lower in T1 group than C
and T3 groups (P<0.05) while P level was higher in C in comparison both T3
(P<0.01) and T1 (P<0.05)calves. Uric acid showed a difference between the
treated groups: T1 showed a higher value compared to T3 (P<0.05). The group
being fed 3.0%/milk replacer calcium diformate highlighted the greatest value in
Ca and formate content in respect to T1 and C (P<0.05).
No statistical differences were detected in the leukocyte formula among the
three experimental groups.
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Table 7: Haematological parameters, biochemical and metabolic values in veal calves during the trial
(A,B= P≤0.01; a,b=P≤0.05).
GROUP P
ITEM C T1 T3 SEM Ca
Haematological parameters
RBC (106/µl) 5.51a 4.95Bb 5.62A 0.18 0.02
Hb (g/dl) 9.06A 8.13Bb 8.71a 0.02 ≤0.01
Ht (%) 19.78A 17.78B 20.20A 0.55 ≤0.01
Reticulocytes (%) --- --- --- --- ---
RPI --- --- --- --- ---
MCV (fl) 36.05 35.91 36.04 0.43 0.97
MCH (%) 17.95 17.98 16.46 0.61 0.17
MCHC (%) 49.56b 50.01b 45.52a 1.29 0.04
RDW (%) 27.62 26.94 27.54 0.33 0.28
PLT (103/µl) 542.97b 606.89a 580.65 22.72 0.13
MPV (fl) 5.91 6.00 5.93 0.06 0.55
PCT (%) 0.36 0.37 0.37 0.03 0.97
PDW (%) 6.47 6.73 6.76 0.12 0.15
WBC (103/µl) 8.41 7.81b 9.06a 0.41 0.12
Serum parameters
Albumin (g/L) 30.21 30.93 28.73 0.29 0.22
ALP (UI/L) 384.48 305.83 326.53 35.25 0.26
ALAT (UI/L) 66.77 66.44 60.05 3.93 0.42
GGT (UI/L) 37.75 34.78 28.81 4.67 0.41
Creatinine (µmol/L) 97.20 98.38 93.63 1.86 0.19
Glucose (mmol/L) 5.52 5.30 5.11 0.21 0.39
Cholesterol (mg/dL) 67.79 65.85 58.72 6.81 0.62
Triglicerydes (mg/dl) 38.32A 33.08 29.63B 2.29 0.04
Total Protein (g/L) 57.83 55.78 55.80 0.78 0.09
Bilirubin (µmol/Ll) 3.83 3.88 3.86 0.16 0.97
Haptoglobin (g/L) 0.49 0.55 0.69 0.06 0.61
Pepsinogen (mμTyr/) 1.31a 0.96b 1.36a 0.01 0.03
Urea (mol/L) 2.64 3.13 2.96 0.21 0.25
Uric-Acid (mg/dl) 0.97 0.94a 1.02b 0.05 0.14
Fe (µg/dl) 77.73 87.25 85.51 9.93 0.76
Mg (mmol/L) 0.89 0.88 0.88 0.01 0.91
P (mmol/L) 3.20Aa 2.87b 2.59B 0.05 ≤0.01
Ca (mmol/L) 2.68b 2.73 2.83a 0.04 0.06
Formate (g/100g) ≤0.01B ≤0.01B 0.02A ≤0.01 ≤0.01
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Table 8:  Leukocyte formula in veal calves during the trial.
Considering the single sampling (Tab.9a,b) at time 0, RBC (P<0.05), Hb
(P<0.01), Ht (P<0.05), RDW (P<0.05) basophiles (P<0.05) and total protein
(P<0.05) resulted higher in C than T1; while Hb (P<0.05), pepsinogen (P<0.01),
and uric-acid (P<0.05) resulted lower in T1 calves compared to T3 groups; PDW,
instead, was greater in T3 compared to C (P<0.05). On 42nd day of
administration, Ht was higher in C (P<0.05) and T3 (P<0.01) compared to T1,
while MCH (P<0.05) and MCHC (P<0.05) resulted greater in T1 than T3. The
same trend was observed for PLT: higher in T1 group than in C calves (P<0.05).
In the third considered time, WBC was greater in T3 than T1 (P<0.05). On the
contrary, basophiles were lower in T3 than T1 (P<0.05) (Tab.10).
During the trial the metabolic status of the animals in the three experimental
groups was found to be very similar with minor variations in serum parameters
(Tab.11a,b).
Initial GGT was higher in C animals than in T3 (P<0.05). Most of the
differences were evidenced on 42nd day of the trial, when albumin was greater in
T1 than in C (P<0.05); on the contrary, the triglycerides highlighted a higher
value in C than T1 (P<0.05) and T3 (P<0.01),  and in T1 resulted higher than T3
(P<0.05). At the end of the trial, the creatininine resulted lower in T3 than T1
(P<0.05).
The P content, upon the second sampling, was higher in not supplemented
animals than T1 (P<0.01) and the latter was higher than T3 (P<0.01) (Tab.11c),
while the Ca serum presence was greater in C and T1 groups than T3 (P<0.01).
The groups T3 and T1 highlighted a higher formate content (P<0.01) than C
subjects (Tab.11c).
GROUP P
ITEM C T1 T3 SEM Ca.Diform.
Leukocyte formula
Neutrophils (%) 27.85 25.32 28.16 2.00   0.59
Limphocytes (%) 53.68 56.42 54.08 1.89   0.55
Monocytes (%) 13.46 14.48 12.88 0.89   0.48
Eosinophils (%)   4.22   3.33    3.72 0.71   0.66
Basophils (%)   1.21   1.14    1.07 0.05   0.29
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Table 9a: Haematological parameters in veal calves at 0, 42 and 84 days of the trial
(A,B= P≤0.01; a,b=P≤0.05)
TIME GROUP P
ITEM (Day) C T1 T3 SEM GROUP TIME G*T
RBC 0 7.54a 6.61b 7.26 3.03 0.02 ≤0.01 0.39
(106/µl) 42 5.10 4.35b 5.45a
84 3.90 3.91 4.15
Hb 0 10.75A 9.48Bb 10.45a 0.35 ≤0.01 ≤0.01 0.21
( g/dl) 42 8.68A 7.28B 8.15
84 7.76 7.63 7.52
Ht 0 23.38a 24.56b 26.59 0.95 ≤0.01 ≤0.01 0.37
(%) 42 18.31a 15.17Bb 19.04A
84 13.71 13.64 14.99
MCV 0 36.26 37.41 36.86 0.75 0.97 0.05 0.41
(fl) 42 36.53 35.69 35.34
84 35.35 34.62 35.92
MCH 0 14.48 14.77 14.80 1.08 0.17 ≤0.01 0.56
(%) 42 18.68 18.94a 15.87b
84 20.67 20.23 18.70
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Table 9b: Haematological parameters in veal calves at 0, 42 and 84 days of the trial
(A,B= P≤0.01; a,b=P≤0.05)
TIME GROUP P
ITEM (Day) C T1 T3 SEM GROUP TIME G*T
MCHC 0   39.80   39.35   40.02   2.23   0.04 ≤0.01   0.33
(%) 42   50.47    52.20a     44.47b
84   58.42   58.49   52.08
RDW 0    30.34a     28.48b   29.76   0.57   0.28 ≤0.01   0.20
(%) 42   26.14   25.53   26.76
84   26.37   26.81   26.09
PLT 0 641.58 721.83 678.64 39.32   0.13 ≤0.01   0.50
(103/µl) 42  450.83b   566.67a 550.55
84 536.48 532.17 512.76
MPV 0    5.92     6.04    6.02   0.09   0.55   0.37   0.90
(fl) 42    5.89     5.94    5.93
84    5.91     6.04    5.85
PCT 0 0.38 0.45 0.41 0.04 0.97 0.04 0.73
(%) 42 0.36 0.35 0.34
84 0.35 0.31 0.37
PDW 0     6.70b   6.78     7.01a 1.15 0.15 0.08 0.77
(%) 42   6.35   6.66   6.78
84   6.35   6.77   6.49
WBC 0   7.34   7.15   7.63 0.72 0.12 ≤0.01 0.75
(103/µl) 42   8.78   8.07   8.95
84 9.11 8.23b 10.59a
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Table  10: Leukocyte formula in veal calves at 0, 42 and 84 days of the trial
(A,B= P≤0.01; a,b=P≤0.05)
TIME GROUP P
ITEM (Day) C T1 T3 SEM GROUP TIME G*T
Leukocyte formula
Neutrophils 0 22.07  8.83 11.53 3.33 0.59 ≤0.01 0.11
(%) 42 32.81 38.21 38.58
84 28.68 28.86 34.36
Lymphocytes 0 71.57 83.47 81.75 3.03 0.55 ≤0.01 0.13
(%) 42 46.83 43.33 43.25
84 42.63 42.48 37.26
Monocytes 0   6.90   9.13   5.40 1.52 0.48 ≤0.01 0.29
(%) 42 15.48 15.65 13.18
84 18.01 18.67 20.06
Eosinophils 0 ---   0.02 0.05 1.24 0.66 ≤0.01 0.71
(%) 42   3.43   1.38 3.62
84   9.23   8.58 7.50
Basophils 0     0.88a     0.56b 0.76 0.09 0.29 ≤0.01 0.09
(%) 42   1.45   1.43 1.37
84   1.30     1.42a 1.07b
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TIME GROUP P
ITEM (Day) C T1 T3 SEM GROUP TIME G*T
Albumin 0 28.21 28.85 29.12 0.50 0.22 0.01 0.17
(g/L) 42  30.35b  31.85a 31.49
84 32.08 32.09 30.96
ALP 0    122.21    129.37 135.47 55.75 0.26 ≤0.01 0.71
(UI/L) 42    539.68    408.73 481.47
84    491.55    379.40 362.19
ALAT 0 65.65 63.14 53.05 6.22 0.42 0.50 0.60
(UI/L) 42 69.66 70.50 56.80
84 65.00 65.68 70.28
GGT 0   69.09a 54.98  38.59b 7.39 0.41 ≤0.01 0.28
(UI/L) 42 22.99 22.66 23.50
84 21.16 26.68 24.33
Creatinine 0    108.64    105.23 105.13 2.95 0.19 ≤0.01 0.58
(µmol/L) 42 92.81 95.53 91.46
84 90.16   94.38a 84.29b
Glucose 0  5.55   5.03  4.70 0.34 0.39 0.34 0.34
(mmol/L) 42  5.24   5.09  5.59
84  5.78   5.77  5.03
Cholesterol 0 55.36 45.46 42.58 10.63 0.62 ≤0.01 0.87
(mg/dL) 42 59.75 70.96 53.22
84 88.25 81.13 80.34
Triglicerydes 0 22.95  25.42 23.25 3.71 0.04 ≤0.01 0.02
(mg/dL) 42 47.09Aa 33.92b 22.98Bc
84 44.92 39.92 42.67
Table  11a: Biochemical and metabolic parameters at 0, 42 and 84 days of the trial
(A,B= P≤0.01; a,b,c=P≤0.05)
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Table  11b: Biochemical and metabolic parameters at 0, 42 and 84 days of the trial
(A,B,C= P≤0.01; a,b=P≤0.05)
TIME GROUP P
ITEM (Days) C T1 T3 SEM GROUP TIME G*T
Total Protein 0 53.28a 50.40 48.50b 1.25 0.09 ≤0.01 0.61
(g/L) 42    58.74    57.48      57.95
84    61.46    59.45      60.30
Bilirubin 0 3.34 3.97 3.70 0.26 0.97 0.34 0.48
(µmol/L) 42 4.11 3.97 3.88
84 4.04 3.72 4.01
Haptoglobin 0 0.67 0.75 0.67 0.08 0.61 ≤0.01 0.95
(g/L) 42 0.51 0.55 0.61
84 0.28 0.36 0.39
Pepsinogen 0 1.40   0.97B  1.67A 0.02 0.03 0.36 0.74
(mμTyr/L) 42 1.30 1.00 1.22
84 1.26 0.92 1.18
Urea 0  4.78 5.00 4.14 0.36 0.25 ≤0.01 0.11
(mmol/L) 42  1.71b 2.57  3.08a
84 1.43 1.82 1.66
Uric-Acid 0 1.22  1.12b  1.26a 0.05 0.14 ≤0.01 0.38
(mg/dL) 42 0.86 0.91 0.99
84 0.82 0.79 0.81
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Table 11c: Calcium and Formate content at 0, 42 and 84 days of the trial (A,B= P≤0.01; a,b=P≤0.05)
TIME GROUP P
ITEM (Days) C T1 T3 SEM GROUP TIME G*T
Fe 0 184.18 204.62 172.25 16.78 0.76 ≤0.01 0.61
(µg/dL) 42 23.08 25.62 32.43
84 25.92 31.53 51.84
Mg 0 0.88 0.89 0.92 0.02 0.91 ≤0.01 0.25
(mmol/L) 42 0.89 0.84 0.84
84 0.92 0.91 0.91
P 0 2.77 2.70 2.68 0.04 ≤0.01 ≤0.01 ≤0.01
(mmol/L) 42   3.29A  2.49B   1.76C
84 3.55 3.42 3.32
Ca 0 2.43 2.57 2.55 0.07 0.06 ≤0.01 0.27
(mmol/L) 42  2.82A  2.85A  2.19B
84 2.80 2.76 2.75
Formate 0 ≤0.01 ≤0.01 0.01 ≤0.01 ≤0.01 ≤0.01 ≤0.01
(g/100g) 42 ≤0.01B ≤0.01B 0.04A
84 0.01 0.01 0.01
148
5.5.3 Faecal score and Microbiological status
The data regarding faecal score avaluation, pH determination and
microbiological status are reported in table 12.
During the trial, the faecal score was significantly lower in T3 animals compared
to C group (P<0.05), while no differences were detected during each considered
time. Faecal pH did not show differences between groups, and the same trend
was observed on 0, 42nd and 84th day of supplementation. Considering all the
trial, C group highlighted an higher presence of coliforms than T1 (P<0.01). The
coliforms and E.coli were statistically higher (P<0.01) on day 0 in T1 group than
in T3 and C and on the 84th day, instead, C groups showed an higher E.coli
values than T3 (P<0.01).
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Table 12: Faecal parameters and microbiological status in veal calves at 0, 42 and 84 days of the trial
(A,B= P≤0.01; a,b=P≤0.05)
TIME GROUP P
ITEM (Week) C T1 T3 SEM GROUP TIME G*T
Faecal Score 0 2.31 2.19 2.20 0.11 0.04 ≤0.01 1.00
(Scale) 1 2.50 2.44 2.53
2 2.54 2.61 2.58
3 2.71 2.73 2.65
4 2.71 2.65 2.60
5 2.67 2.77 2.63
6 2.81 2.71 2.65
7 2.85 2.79 2.70
8 2.98 2.98 2.88
9 3.04 2.96 2.83
10 2.85 2.90 2.75
11 2.88 2.83 2.65
12 2.90 2.77 2.68
0-12 2.75a 2.72 2.64b 0.04 0.04
Days
Faecal pH 0 7.28 7.84 7.63 0.34 077 0.02 0.57
42 8.09 7.28 7.85
84 6.90 6.80 6.92
0-84 7.42 7.31 7.46 0.16 0.46
Coliforms 0 8.20B 9.52A 8.04B 0.25 0.03 ≤0.01 0.02
(Log10) 42 6.79 6.57 6.7484 6.03B 6.27 6.91A
0-84 7.00B 7.45A 7.23 0.17 0.03
E. coli 0 8.19B 9.45A 7.89B 0.27 0.17 ≤0.01 ≤0.01
(Log10) 42 6.94 6.21 6.5984 5.95b 6.45 6.90a
0-84 7.03 7.37 7.13 0.12 0.07
Lactobacilli 0 9.58 9.70 9.76 0.39 0.28 ≤0.01 0.52
(Log10) 42 8.74 8.84 7.7884 9.50 9.30 9.14
0-84 9.27 9.28 8.89 0.18 0.17
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5.5.4 Health status during the trial
During the first phase of the trial, the calves received an antibiotic treatment
(amoxicillin plus colistin) and a Cryptosporidium parvum prevention treatment; at the
end of the adaptation period, all animals involved in the trial were found in good
general health conditions. Diarrhoea was detected during the three weeks
following beginning of the treatment (Tab. 13). No diarrhoeic phenomena were
evidenced for the rest of the trial period in the three experimental groups. T1
and T3 animal had diarrhoea during the first week of the trial and with less days
of presence than the C animals that, on the contrary, evidenced the problem in
one subject until the third week of the study.
Week 1 Week 2 Week 3
Group n. of
calves Diarrhoea*
n. of
calves Diarrhoea*
n. of
calves Diarrhoea*
C 3 3.67 1 2.00 1 3.00
T1 4 3.00 0 0.00 0 0.00
T3 4 3.25 0 0.00 0 0.00
* Days mean
Table 13: Number of calves and mean days in diarrhoea during the first three weeks of the trial
At the beginning of the second phase a total number of 1 animal in C, 3 animals
in T1 and 4 animals in the T3 group were sent to the Veterinary Faculty Clinics.
Moreover, 1 subject of T3 group was treated two times during the trial by the
Veterinary Clinics.
Most of the therapeutic treatments were performed due to respiratory problems
and hyperthermia with a concomitant general health depression.
During the trial, 3 animals from T3 group died. The performed necropsy
evidenced an increase in gastrointestinal tract lynphonodes dimension, while no
clinic signs were detected on esophagus mucosae.
In detail, all dead subjects showed moderate to severe ruminal constipation due
to the presence of large amounts of dry ingesta and multifocal mucosal
hemorrhages.
The first calf showed multifocal to coalescing necrotizing hemorrhagic foci and,
at histological examination, micotic ife (mucor micosis) was found.
The second animal evidenced moderate fibrinous peritonitis, moderate catarrhal
abomasitis and mild but diffuse catarrhal enteritis.
The third subject had moderate fibrinous pleuritis and severe, diffuse, gangrenous
bronchial pneumonia with huge and diffuse pulmonary edema.
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5.5.5 Slaughtering evaluations
Slaughtering weight resulted lower in treated gropus compared to C
(C=121.00kg vs T1=112.17kg vs T3=108.74kg; P<0.01).
Carcass weight was lower (P<0.01) in T3 (58.87kg)  than C (67.49kg) (Tab.14),
while the administration of calcium diformate did not influenced organ Ca and
formiate content, organ weight, and carcass dressing percentage.
5.5.6 Histological and histometrical analyses at the slaughter
At slaughtering no differences were detected from a clinical examination of lungs,
liver, kidney and total gastrointestinal tract of the animals. In particular no ulcers
were found in the three experimental groups and no differences were detected in
villous height, cripth dept and their ratio (Tab.15).
The microscopic examination of the intestinal sections revealed altered structural
aspects of the intestinal mucosa corresponding to catarrhal enteritis with no
detectable differences between C calves and T calves. Epithelial detachment in
the intestinal villous associated with mucous secretion excess was detected
(Fig.1,3 and 5). Some diffuse mixed cellular infiltration (Fig. 4 and 6) in the sub
mucosa and lamina propria was also detected. The most evident difference between
C and T1/T3 calves was concerning the sub mucosal Brunner glands, which
were fully normal in either aspect in C calves (Figs 1, 2) but showed empty and
enlarged lumen in treated animals (Figures. 3,4,5 and 6). In addition, the
histological signs of mucous secretions appeared scarce.
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Table 14: Slaughter performance of veal calves and calcium and formiate organ content
(A,B=P≤0.01;a,b=P P≤0.05)
GROUP
MEASURE* C T1 T3
Villi height (µm) 344.43±9.37 331.67±8.84 348.47±10.02
Crypts depth (µm) 355.44±7.70 352.76±7.26 373.28±8.24
V:C ratio 0.98±0.02 0.95±0.02 0.94±0.02
Table 15: Effect of the calcium diformate on villous height, crypt depth and their ratio in veal calves
(*values are means±SEM)
GROUPS P
ITEM C T1 T3 SEM CaFO
Slaughtering weight (kg) 121.00A 112.17B 108.74B 0.76 0.01
Carcass weight (kg) 67.49A 63.25 58.87B 2.55 0.02
Dressing percentage (%) 55.81 56.54 55.75 1.19 0.78
Organ weight (g)
Liver 2,628.92 2,376.67 2,208.00 293.68 0.43
Kidney 543.83 496.50 545.75 42.73 0.46
Organ Formiate content
(g/100gDM)
Liver ≤0.01 ≤0.01 ≤0.01 --- ---
Kidney ≤0.01 ≤0.01 ≤0.01
Muscle ≤0.01 ≤0.01 ≤0.01
Fat ≤0.01 ≤0.01 ≤0.01
Organ Ca content
(mg/100gDM)
Liver 272.83 212.33 273.23 42.46 0.52
Kidney 225.11 328.36 244.95 48.83 0.25
Muscle 455.86 379.23 515.27 99.59 0.63
Fat 99.40 138.50 123.49 20.70 0.42
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Figures 1-6: In the intestinal villous it can be observed an epithelial detachment associated with mucous
secretion excess (Figure 1,3 and 5). In the sub mucosa and lamina propria it can be highlighted a diffuse
mixed cellular infiltration (Figure 4 and 6  granulocytes, lymphocytes and plasma cells; white asterisks)
The sub mucosal Brunner glands are fully normal in either aspect in C calves (Fig. 1, 2; in Fig 2: black
thin arrows) but show empty and enlarged lumen in treated animals (Figures. 3,4,5 and 6; in 4 and 6:
black thin arrows).
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5.6 Discussion
The veal calves are very often subject to enteric and respiratory diseases due to
multifactorial stress and the administration of substances alternative to
antibiotics is critical for the consumer’s safety.
In this context, the major outcomes using organic acids include bactericidal and
bacteriostatic actions (Luckstadt et al., 2011).
The formic acid salts administered in form of calcium formate present not-
recent and not extensive literature, especially concerning veal calves. Only a few
studies were conducted to verify the effects of administration of this compound
in piglets and broilers, as well as to determine the toxicity at different doses in
dairy cows but, in some cases, the reported results in literature are conflicting.
In piglets, a reduction of dry matter intake was observed (Bindas et al., 1998), on
the contrary, Bosi et al. (2005) found an increase of DMI that lead to similar BW
but increased ADG between treated and no treated animal confirming results
obtained Bindas et al. (1998) and Kirchgessner et al. (1997) who also found
increased feed effiency.
The improvement of growth performance using acidifiers in the drinking water
was also evidenced in poultry by Cornelison et al. (2005), but higher inclusion
levels of organic acids could reduce weight gain and feed efficiency (Patten et al.,
1997). More recently, however, as a result of correct microflora balancing,
Philipsen et al (2006) observed an increase in broiler food efficiency, promoting
the growth performance. Positive effects on ADG and FCR were also found in
chicken with a combination of formic acid and propionic (Desai et al., 2007),
raising gastric proteolysis and improving the proteins and amino acids
digestibility (Samanta et al., 2010).
Differently from some authors, the results obtained in the present trial on
growth performance of veal calves showed a reduced dry matter intake.
The general observed intake reduction effect of milk replacer could be attributed
to a lower product palatability that consequently leads to negative findings over
growth and slaughtering performance in the treated groups as reported by
Partanen and Mroz (1999) who found higher level of organic acids responsible
for a reduction of BW as a result of decreased feed intake
Moreover it appears that the response of growth paramenters to the acid
supplementation is associated with several factors such as the acid type, the
inclusion level, the acid buffering capacity of the basal diet, the stage of growth
and the health status of treated animals (Che et al., 2012). Among these factor,,
growth promoting effects of dietary organic acids appear to be dependent on the
chemical composition of the diet. The greatest benefits have been observed
when diets were formulated with cereals, while the growth promoting effect was
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smaller in diets containing milk products (Easter, 1988; Partanen and Mroz,
1999). In addition to this, a high intake of calcium is known to enhance the
formation of calcium fatty acid soaps in the digest, which also reduces fat
digestibility (Xu et al, 1999). Moreover Ravindran and Kornegay (1993)
suggested that a better performance could be expected in suboptimal rearing
conditions.
Several haematological values in young calves differ from adult reference
intervals. These age-related factors should be kept in mind when assessing
hematologic values in calves (Hege et al., 2006). In the present trial most of
haematological variations observed in calcium-diformiate supplemented animals
respect to basal-diet fed calves are negligible considering the dietary treatment
not influencing the haematological balance.
Evidenced RBC count variations during the present trial, expecially in the ﬁrst 5
to 8 weeks of life than later, could be attributed to iron content or iron
availability of diet as reported by Hege et al. (2006).
Serum pepsinogen has been used to detect abomasal necrosis (Zadnik and
Mesaric, 1999) and is used with haptoglobin as a biochemical marker of
abomasal inflammation in dairy cows supplemented with calcium formiate
(McIntyre et al., 2002). The supplementation of organ acid could reduce stomach
pH, stimulating the pepsinogen to pepsin conversion (Luckstadt et al., 2011): in
the present trial serum pepsinogen content resulted higher in C and T3 calves
than T1, so it canot be attributable to the treatment in accordance with McIntyre
et al. (2002).
Moreover the decreased levels of Haptoglobin in all the considered groups
during the trial should confirm the absence of an inflammatory status.
In the entire considered period, faecal score was decreased in treated animals
than control contrarily to Jaster et al. (1990) and Ribeiro et al. (2009) who did
not observe any variations of faecal score in calves, but results can be often
variable in calves fed acidifiers (Zanetti et al., 1999; Heinrichs et al., 2003;
Timmerman et al., 2005).
Higher faecal coliforms and, in particular, E. coli during the trial in T groups are
not in agreement with findings by Luckstadt et al. (2011) and the supposed to
bactericidal mechanism of action of salts of organic acids that should result in a
Gram- reduction (i.e. Salmonelle and E.coli), as observed in piglets (Bindas et
al.,1998) and broilers (Izat et al., 1990; Al-Tarazi and Alshawackeh, 2003).
Pathogenic bacteria reduction by lower intestinal pH valueds, hould esitate in a
better nutrient absortion due to the lower competion for nutrients, with less
digestive problems such as diarrhoea (Ribeiro et al., 2009): in the present trial no
alteration of intestinal pH was observed.
However this mechanism may not be effective, because organic acids with pH
value of 5.0 or higher would probably not have bactericidal or bacteriostatic
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effects and calves fed organic acids reduce the production of hydrochloric acid
through the gastric juice to compensate the hight feed acidity (Jaster et al., 1990).
Moreovoer, according to Jaster et al. (1990) and Merchen et al. (1996), animals
react to the intestinal acidity producing greater amounts of bile and pancreatic
juice to make the intestinal pH stable and to provide the appropriate
environment for the action of digestive and absorptive enzymes.
The incidence of mortality and the causes of sudden deaths observed during the
trial can not be ascribed to dietary treatments excluding a toxic effect by the
absence of ulcers and changes in the duodenal mucosa at the time of death
although reported data concerning calcium diformiate toxicity are conflicting.
McIntyre et al. (2002) do not show signs of toxicity at the slaughterhouse in
adult cows supplemented with Ca formate, even if abomasal inflammation was
highlighted, while Scott et al. (2000) observed necrotic abomasal areas in cows.
No differences were shown regarding the duodenal morphology differently from
Bosi et al. (2005), who observed a higher villous height, but in piglets, attributable
to a good intestinal function and absence of inflammatory phenomena or
diarrhoea that may affect the morphological appearance of the intestine.
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5.7 Conclusions
The administration of both 1% and 3%/milk powder of calcium diformiate in
veal calves decreased the growing performance of the treated animals, but not
carcass dressing percentage, while  no major differences were detected between
the experimental groups in haematological, serum, and immune response
investigated parameters.
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6 General Discussion
In order to obtain the maximum economic yield in veal calf’s and replacement
heifer’s breeding, it is essential to optimize the growth performance and the health
status. Various factors such as a good health status, a proper management and
correct applicated nutritional strategies are essential to avoid economic losses. The
health status of the young calves is mined by enteric and respiratory diseases:
specifically the neonatal diarrhoea represents the main cause of mortality and
morbidity and it is often due to an enteric pathogen: the Escherichia coli. The
enterohaemorrhagic E.coli (EHEC) is recognized as an infectious of food products
(Lee et al., 2007), whose contamination can occur by the ingestion of uncooked
food, polluted with the faeces of infected animals. The European Community ban
of antibiotics like growth promoters (2006) induced to test more additives, for
instance probiotics and acidifiers, able to promove the growth performance
through the improvement of  health status and intestinal and immunitary status.
In our experimental trials, the administration of a species-specific probiotic
(Bacillus coagulans, Lactobacillus animalis and Lactobacillus paracasei spp. paracasei ) both
in veal calves and replacement heifers, and an acidifier (calcium diformate) in veal
calves, did not allow to obtain univocal effects in relation to microbial status,
health status and growth performance.
It has been possible observed how, in respect of a different management and a
different breeding production target, the general health status is overall improved,
iven if not significantly, in both the experimental trials wich have provided the
probiotic as a supplement in the diet.
In fact, despite the veal calves often do not receive an adequate colostrum
administration and the veal rearing involves a stressing situation, the probiotic
allows to highlight an improvement of animals’ health compared to the control
animals, not only through a better GHS score, but also reducing the mortality and
morbidity rate as reported by Timmerman et al. (2005). This trend is also
confirmed by some authors who stated as the response to the treatment is clearly
visible mainly in the animals with compromised health status (Spanhaak et al.,
1998; Timmerman et al., 2004).
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Probiotic administration is reported to henhance health status through the
improvement of immune condition (Fleige et al., 2008; Frizzo et al., 2010;
Buddington et al., 2011) and the reduction of the respiratory  (Hatakka et al.,
2001; Tsuruta et al., 2009) and enteric (Mokhber et al., 2007; Nagashima et al.,
2010; Frizzo et al., 2010; Kawakami et al., 2010) pathologies: in our trials the
lower severity of enteric diseases is demonstrated by an higher faecal consistency.
Otherwise the administration of calcium diformate, in spite of the supplement’s
antimicrobial action could improved the general health status, does not allow to
observe neither a reduction of mortality and morbidity rate nor an improvement
of faecal consistency. The better faecal consistency in animals represents an
index of a better gut microbial status: this balance is undermined in the calves
subject to enteric pathologies in the few weeks of life (Gaggia et al., 2010). The
Lactobacillus genus population is a natural component of intestinal microflora in
several species (Schneider et al., 2004) and also in calves (Rada et al., 2004). The
population of Lactobacilli is able to influence the process of homeostasis (Novik
et al., 2006) which allows the control of certain gut epithelium function (Heyman
and Menard., 2002), as well as the control of some pathogens’ species that
colonized the gut such as Salmonella (Gill et al., 2001) and E.coli (Shu and Gill,
2002). In good healthy condition, the Lactobacilli count is higher than the
coliforms count, but the situation is reversed in case of intestinal pathologies and
stress (Abu-Tarbush et al., 1996; Signorini et al., 2007). In the latter case it can be
observed an unbalanced ratio between Lattobacilli and E.coli.
Our two trials confirm the positive effects reported in literature in calves
supplemented with probiotic, emphasizing a statistical higher value referred to
Lactobacilli count (Lalles et al., 2007; Corcionivoschi et al., 2010; Frizzo et al.,
2011; Kawakami et al., 2010) at the fourth considered sampled in veal calves, and
a better significant trend in the Lactobacilli/E.coli ratio in dairy calves. In veal
calves this tendency is concurrently with the suspension of mass antibiotic
treatments corresponding to the third considered month. The organic acid
bactericidal action, in which the lactic acid bacteria are extremely less sensitive
(Luckstadt et al., 2011) is not confirmed in our trial in veal calves, in contrast
with a reduction of gram negative bacteria observed in broilers (Izat et al., 1990;
Mroz et al., 2005; Mikkelsen et al., 2009) and in piglets (Dennis et al., 2004;
Lyinch et al., 2007; Correge et al., 2010) and an increment in the population of
Lactobacilli and Bifidobacteria in broilers (Luckstadt and Theobald, 2009).
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Thus the observed enhancement of the intestinal microbial status in calves
supplemented with probiotic can be related with the improvment of health
status and faecal consistency, thas should lead to higher growth performance. In
our trials, the administration of probiotic in veal calves showed no increase in
body weight, unlike what is observed in dairy calves, the last one in agreement
with Al-Saiady et al. (2010) and Hossaini et al. (2010). In the latter, the
concentrate intake also significantly improved in the whole considered period,
according with Timmerman et al. (2005) and LeJeune and Wetzel (2007), while
weight gain and feed efficiency did not change in both reported trials. Anyway
still at the moment literatures are conflicting: some authors reported no
improvement in body weight (Frizzo et al., 2010; Morrison et al., 2010) or in
relation to feed efficiency (Bakhshi et al., 2006; Riddel et al., 2010). These
discrepances would be attributed to different factors, indivuals and managerials.
It also can be assumed that the administration of antibiotic treatments of mass
may not allow a total completion action of the probiotic. The absence of any
enhancing in growth performance in calves supplemented with calcium
diformate, contrary to what observed in calves by Woodford et al. (1987) but in
agreement with Jaster et al. (1990) and Xu et al. (1999) is instead due to a
significantly reduced feed intake wich results in a statistically lower body weigth
in treated animals and a deterioration of the slaughter performance. From the
presented trials, it can be concluded that the administration of a species-specific
probiotic compound can determine several positive effects on growth
performance and health status as a function of an improvement of the
microbiology in the gut, although it should be noted that an high incidence of
antibiotic treatments can affect the efficacy of the product, as found in our test
in veal calves. This ipotesis is supported by the data reported in vitro that show an
higher inhibition halos in plates treated with eight different classes of
antimicrobial agents  (Ripamonti et al., 2012 in press), while the administration of
calcium diformate in calves should be further explored, pointing out the correct
dose which can improve the intestinal microbial status.
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7 Summary
The purpose of the present trials was the evaluation of the effects both a
species-specific probiotic administration in veal (1st trial) and dairy calves (2nd
trial) than an acidifier supplementation in veal calves (3rd trial) on health status,
gut microbial balance and growth performance. On veal calves the effects of
probiotic and acidifier on slaughter performance and histological survey were
further evaluated.
The aim of first the study was to evaluate the effects of the administration of a
species-specific probiotic supplement to veal calves on performance and
microbial parameters in standard rearing conditions. Ninety six male Friesian
veal calves (49.31 ± 1.38kg of body weight and 20±5 days of life) were divided at
random in two homogeneous groups of 48 animals each from the arrival in the
farm and fed either a basal diet (C) or a basal diet plus 1.8x109 CFU/head/day of
a probiotic supplement containing Bacillus coagulans, Lactobacillus animalis and
Lactobacillus paracasei spp. paracasei in a 35:30:35 ratio (T) for a total of 180 days.
Starting from 10th day from arrival and monthly until the end of the trial,
individual body weight (BW) was recorded and average daily gain (ADG) was
computed. At the same time, on the half of animals per group, faecal samples
were collected for faecal score evaluation (FS), Lactobacilli count, Escherichia coli
count and Lactobacilli/E.coli ratio, while blood samples were collected for
haematological, haematochemical and immunological parameters evaluation.
During the whole experimental period daily health status and therapeutic
treatments were recorded for General Health Score (GHS) determination. At
slaughter 10 animals per group were analysed for macroscopically injuries
detection, and gut samples were collected for histological analyses. On each
subject carcass weight, dressing percentage, fattening condition, carcass grade
(SEUROP classification) and meat pH were recorded. During the trial were
considered six times (corresponding to the each month of fattening): from time
0, referred to the 10th day from arrival, to the last considered month (time 6).
BW resulted significantly higher (P≤0.05) in C calves than T at the 5th
(C=226.76kg vs T=223.27kg) and 6th (C=267.14kg vs T=263.56kg) considered
times while ADG was not different between groups. Faecal consistency was,
significantly higher in T group at the 4th sampling (P≤0.01) as faecal Lactobacilli
content (C=8.37 Log10 vs T=8.49 Log10; P≤0.05). This trend could explain thebetter GHS observed in supplemented calves during the trial.
At different times, some haematological parameters such as basophils, aspartate
amino transferase (AST), bilirubin, glucose, urea, bactericidal and complement
were higher (P<0.05) in C group, while non-esterificated fatty acids (NEFA) and
lactate dehydrogenase (LDH) showed lower values than T (P<0.05).
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 At slaughter no differences were observed for carcass weight, dressing
percentage, carcass grade and meat pH. The cecum histological examination
revealed a less evident de-epithelialisation and a greater integrity of the
epithelium surface in T subjects than C, while in both the ileum than in cecum a
numerical increase of the intestinal crypts’ depth was detected. The
administration of species-specific probiotic was able to improve the gut
microbiological balance and health status with not no evident effects on growth
performance.
The second study evaluated the effects of the administration of a species-specific
multistrain probiotic (Lactobacillus animalis-Lactobacillus paracasei subsp. paracasei-
Bacillus coagulans; 30:35:35) on health and performance parameters of newborn
Friesian female calves during the first month of life.
Twenty-two calves were divided in two groups: control (C) fed with milk
replacer and concentrate as a basal diet, and treatment (T), fed C diet plus
1g/head/d of probiotic from the second day after birth to the end of the first
month of life. Faecal samples were collected weekly for the count of Lactobacilli
and Escherichia coli; blood samples were collected and analyzed weekly. Individual
FS was recorded daily, GHS was calculated at the end of the trial, and cell
mediate immune response was evaluated by skin test at 7 and 28 days of life.
Body weight, biometrical parameters and ADG were recorded weekly while Feed
Intake (FI) and Feed Conversion Rate (FCR) were recorded for the overall
period. Higher faecal Lactobacilli/E. coli ratio on day 28 of life (3.73 Log UFC/g
vs. 2.02 Log UFC/g; P<0.05) and improved faecal consistency at 6, 25 and 27d
of life were found in T group. Final body weight (48.92 Kg vs 46.92 Kg; P<0.05)
and hearth girth (81.16 cm vs 78.49 cm; P<0.05) were significantly higher in T
group. Concentrate FI (%DM) was significantly higher in T group overall the
trial period, while ADG, FCR and milk replacer FI (%DM) were not influenced
by probiotic administration. GHS showed increased mean value, but non
significantly, in T group (T=20.45 vs C=18.91). Increased haemoglobin
(10.04g/dl vs 8.60g/dl) and hematocrit (26.68% vs 22.17%) plasma content at 8d
in T group with lower eosinophils percentage (0.05% vs 0.22%) were found at 8d
in T group, while basophiles content was increased at 28d in species-specific
probiotc-fed animals than C (0.21% vs 0.16%, respectively; P<0.05). The
administration of a species-specific probiotic compound during the first month
of life of newborn calves improved gut microflora, increased performance and
some biometric parameters.
The last trial involving 36 male Friesian calves was conducted to determine the
effect of calcium diformate administration and its inclusion level on growth
performance, intestinal balance, metabolism, health status, and calcium and
formate organ content.
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The calves (44.55kg±5.51kg BW, 25±10 days old), were divided in three
homogeneous groups of twelve subjects each: C fed with a basal diet, T1 fed
with a basal diet plus 1%/milk replacer of calcium diformate, and T3 fed a basal
diet plus 3%/milk replacer of calcium diformate for a total of 84 days of
supplementation. During the experimental period daily FI, AD and FCR were
determined. At 0, 42 and 84 days of trial individual blood samples were collected
in order to detect haematological and biochemical parameters, Ca and FO
content. At the same time faecal samples were collected for Lactobacilli, total
coliforms and E.coli count along with faecal pH. Weekly BW and FS were
recorded, while the health status was constantly monitored and the cause of
deaths analyzed by necropsy. At the 91st day of trial the calves were slaughtered:
any presence of ulcers were detected, individual carcass weight and dressing
percentage were determined, and kidney and liver weight recorded. On seven
animals per group liver, kidney, muscle and fat samples were collected and total
Ca and formate were evaluated. The administration of calcium diformate
decreased dry matter intake from either milk powder, concentrate and both milk
powder and concentrate together with increasing level of calcium diformate in
the diet (C=1419,05g/h/d; T1=1217,78g/h/d; T3=1190,73g/h/d; P≤0.01). As
a result, final body weight in treated animals was lower than control calves
(C=121,00kg; T1=112,17kg; T3=108,74kg; P≤0.01). Mean ADG in 3%/milk
replacer CaFO calves was decreased if compared to C subjects (C=0.87kg/h/d
vs T3=0.73kg/h/d; P<0.01), while a similar feed conversion rate was detected
between the experimental groups. Faecal score was decreased in T3 animals
(P≤0.05) than control while no differences were found for faecal pH, E.coli or
Lactobacilli. Higher total coliforms count was evidenced in T1 animals than C
(7.45 Log10 vs T1=2.75Log10 respectively; P≤0.05). At slaughter no differencewas observed for dressing percentage, while carcass weight resulted higher in C
compared to T3 (C=67.49kg vs T3=58.87; P≤0.05). Organ weight and organ
formate and calcium content were similar between the experimental groups.
Red blood cells count (RBC), haemoglobin (HB) and hematocrit (HT) resulted
higher (P≤0.05) in C and T3 than T1, while control calves showed higher
platelets (P≤0.05) value than T1, and greater (P≤0.05) triglycerides than T3.
Mean cell haemoglobin (MCH) value resulted higher (P≤0.05) in T3 subjects
than the other groups. Increased formate blood content in 3% of calcium
difromate/milk replacer animals did not show any differences for organ formate
content thus giving no accumulation. Immune response was not affected by the
treatment and necropsies on dead animals suggest no interaction among
treatment and death itself. The histological examination revealed altered
structural aspects of the intestinal mucosa in all the experimental corresponding
with no detectable differences between control T1 and T3 groups.
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Epithelial detachment in the intestinal villi associated with mucous secretion
excess and some diffuse mixed cellular infiltration sub mucosa and lamina propria
were highlighted. The sub mucosal Brunner glands were in normal physiological
conditions in C, but showed empty and enlarged lumen in treated animals. While
not showing toxic effects in veal calves, the administration of calcium diformate
is not useful in promoting the growth performance and gut balance. In
conclusion, the species-specific probiotic administration in veal and dairy calves
can improve the gut microbial balance and consequently the general health status,
although no effect on growth performance, while the calcium diformate
supplementation, even if not showing toxic effects in veal calves, isn’t helpful to
increase the intestinal microbial balance and the growth performance.
